data_1ced_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ced _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 120.224 0.059 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.966 -0.013 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.81 41.93 27.09 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.382 1.473 . . . . 0.0 111.461 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.07 147.96 42.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.808 0.813 . . . . 0.0 110.723 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt -76.18 -35.98 58.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.484 1.513 . . . . 0.0 110.227 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.334 2.6 mp0 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.12 -137.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.849 1.66 . . . . 0.0 111.075 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -76.41 99.92 5.03 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.02 0.914 . . . . 0.0 109.97 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.12 -26.23 63.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.822 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.57 45.36 25.05 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.066 0.946 . . . . 0.0 110.116 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.91 147.22 47.25 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.346 1.069 . . . . 0.0 111.183 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.4 -47.88 68.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.264 2.226 . . . . 0.0 110.86 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.82 60.63 0.37 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.846 1.258 . . . . 0.0 111.58 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -77.11 152.15 35.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.444 1.098 . . . . 0.0 110.869 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.07 -37.07 61.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.312 1.445 . . . . 0.0 110.039 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 18.5 mp0 . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.96 42.35 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.981 0.912 . . . . 0.0 111.518 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -70.14 147.4 49.96 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.052 0.929 . . . . 0.0 110.853 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -49.41 60.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 110.774 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 43.77 25.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.081 0.855 . . . . 0.0 109.91 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.49 152.97 42.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.859 0.838 . . . . 0.0 111.02 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt -75.53 -36.99 60.36 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.491 1.516 . . . . 0.0 110.24 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.65 -157.16 0.55 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 129.701 3.2 . . . . 0.0 104.059 170.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -78.38 77.98 4.86 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.344 1.884 . . . . 0.0 107.929 169.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.33 -26.67 64.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.911 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 140.94 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.74 2.816 . . . . 0.0 111.144 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -76.89 139.89 40.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 110.789 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.37 -35.42 61.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.753 1.221 . . . . 0.0 110.742 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.26 -162.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.572 0.749 . . . . 0.0 110.048 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.81 115.57 23.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.961 0.8 . . . . 0.0 110.272 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.39 -28.09 64.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.522 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.405 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.31 -138.28 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.803 0.841 . . . . 0.0 109.338 -168.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -100.32 143.12 30.88 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 164.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.52 -29.63 16.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.954 1.302 . . . . 0.0 110.266 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 13.9 mp0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 41.27 31.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.046 0.938 . . . . 0.0 111.517 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.63 148.62 46.37 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.816 0.817 . . . . 0.0 110.845 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.21 -36.46 61.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.284 1.433 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.38 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.09 47.28 2.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.796 1.238 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.89 150.6 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.86 0.838 . . . . 0.0 111.157 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt -74.85 -36.74 62.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.597 1.559 . . . . 0.0 109.98 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 41' ' ' LEU . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 37' ' ' ILE . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 120.224 0.059 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 72' ' ' GLU . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 32' ' ' LEU . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 19' ' ' HIS . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 10' ' ' VAL . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.403 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 72' ' ' GLU . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 10' ' ' VAL . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 45' ' ' PHE . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 41' ' ' LEU . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.53 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.415 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.424 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 90' ' ' HEM . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 62' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.966 -0.013 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.81 41.93 27.09 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.382 1.473 . . . . 0.0 111.461 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.07 147.96 42.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.808 0.813 . . . . 0.0 110.723 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt -76.18 -35.98 58.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.484 1.513 . . . . 0.0 110.227 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 41' ' ' LEU . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 37' ' ' ILE . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.459 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.459 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.334 2.6 mp0 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.12 -137.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.849 1.66 . . . . 0.0 111.075 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -76.41 99.92 5.03 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.02 0.914 . . . . 0.0 109.97 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.12 -26.23 63.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.822 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.417 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.57 45.36 25.05 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.066 0.946 . . . . 0.0 110.116 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.91 147.22 47.25 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.346 1.069 . . . . 0.0 111.183 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.4 -47.88 68.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.264 2.226 . . . . 0.0 110.86 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.409 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.409 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.82 60.63 0.37 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.846 1.258 . . . . 0.0 111.58 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -77.11 152.15 35.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.444 1.098 . . . . 0.0 110.869 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.07 -37.07 61.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.312 1.445 . . . . 0.0 110.039 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.444 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 18.5 mp0 . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.96 42.35 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.981 0.912 . . . . 0.0 111.518 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -70.14 147.4 49.96 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.052 0.929 . . . . 0.0 110.853 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -49.41 60.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 110.774 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 43.77 25.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.081 0.855 . . . . 0.0 109.91 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.49 152.97 42.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.859 0.838 . . . . 0.0 111.02 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt -75.53 -36.99 60.36 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.491 1.516 . . . . 0.0 110.24 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 72' ' ' GLU . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 32' ' ' LEU . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 19' ' ' HIS . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.427 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 10' ' ' VAL . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.403 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.427 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.65 -157.16 0.55 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 129.701 3.2 . . . . 0.0 104.059 170.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -78.38 77.98 4.86 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.344 1.884 . . . . 0.0 107.929 169.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.33 -26.67 64.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.911 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 140.94 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.74 2.816 . . . . 0.0 111.144 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -76.89 139.89 40.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 110.789 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.37 -35.42 61.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.753 1.221 . . . . 0.0 110.742 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 72' ' ' GLU . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.415 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 10' ' ' VAL . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.415 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.26 -162.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.572 0.749 . . . . 0.0 110.048 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.81 115.57 23.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.961 0.8 . . . . 0.0 110.272 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.39 -28.09 64.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.522 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 45' ' ' PHE . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 41' ' ' LEU . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.53 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.421 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.405 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.31 -138.28 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.803 0.841 . . . . 0.0 109.338 -168.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -100.32 143.12 30.88 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 164.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.52 -29.63 16.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.954 1.302 . . . . 0.0 110.266 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.431 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.431 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.424 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 90' ' ' HEM . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 62' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 13.9 mp0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 41.27 31.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.046 0.938 . . . . 0.0 111.517 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.63 148.62 46.37 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.816 0.817 . . . . 0.0 110.845 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.21 -36.46 61.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.284 1.433 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.428 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.415 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.428 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.38 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.09 47.28 2.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.796 1.238 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.89 150.6 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.86 0.838 . . . . 0.0 111.157 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt -74.85 -36.74 62.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.597 1.559 . . . . 0.0 109.98 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HEM . . . . . 0.43 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 41' ' ' LEU . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 37' ' ' ILE . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 120.224 0.059 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 119.214 -0.422 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.437 -1.081 0 N-CA-C 110.774 -0.084 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.447 -0.621 0 CA-C-O 119.177 -0.44 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 72' ' ' GLU . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 32' ' ' LEU . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 19' ' ' HIS . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 10' ' ' VAL . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.403 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 72' ' ' GLU . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 10' ' ' VAL . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 45' ' ' PHE . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 41' ' ' LEU . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.53 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 119.125 -0.464 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 119.276 -0.392 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 119.132 -0.461 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.415 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.424 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 90' ' ' HEM . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 62' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.966 -0.013 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.81 41.93 27.09 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.382 1.473 . . . . 0.0 111.461 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -74.07 147.96 42.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.808 0.813 . . . . 0.0 110.723 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.1 mt -76.18 -35.98 58.89 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.484 1.513 . . . . 0.0 110.227 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.26 -46.5 55.65 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 118.872 0.76 . . . . 0.0 110.172 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -50.22 -57.15 8.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.59 1.156 . . . . 0.0 108.511 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.45 -46.63 29.23 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -61.23 -55.22 34.54 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.683 -0.892 . . . . 0.0 110.779 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.66 -46.62 29.23 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.014 0.526 . . . . 0.0 111.236 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.9 t -59.48 -55.67 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -48.15 -60.39 2.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.118 1.367 . . . . 0.0 111.533 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -47.41 -39.42 15.38 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.893 2.077 . . . . 0.0 111.355 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.66 -45.46 6.41 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -103.04 -37.06 7.93 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.61 0.764 . . . . 0.0 112.387 -160.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 m -105.22 -45.08 4.59 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.466 1.107 . . . . 0.0 109.076 -162.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.55 -31.9 7.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.723 1.209 . . . . 0.0 112.385 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -45.08 1.81 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.771 1.228 . . . . 0.0 112.278 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.2 m -107.2 -28.07 10.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.749 0.82 . . . . 0.0 111.124 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -116.83 32.2 6.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.979 1.312 . . . . 0.0 113.55 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.77 119.45 1.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.937 1.244 . . . . 0.0 111.127 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.78 35.97 90.97 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.745 -0.597 . . . . 0.0 112.754 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.08 11.74 61.65 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.836 -0.802 . . . . 0.0 112.245 -172.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.15 86.14 1.07 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 124.38 0.991 . . . . 0.0 110.962 -164.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -43.54 109.21 0.13 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.738 1.215 . . . . 0.0 110.975 170.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -77.59 -38.82 47.45 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.052 0.541 . . . . 0.0 109.986 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.72 -54.32 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.753 0.421 . . . . 0.0 111.159 -172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.2 mt -119.62 91.36 44.62 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -45.81 -39.95 19.16 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 125.152 3.901 . . . . 0.0 116.216 -162.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -86.57 -21.39 26.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.817 1.647 . . . . 0.0 112.256 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -84.31 41.96 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.048 -1.032 . . . . 0.0 110.624 -171.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -68.19 165.95 17.27 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.262 1.825 . . . . 0.0 112.195 -169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -78.13 28.17 0.18 Allowed 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.191 -0.943 . . . . 0.0 112.373 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -78.33 162.96 26.1 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -57.87 -61.28 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.079 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.46 -49.22 36.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.88 96.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.805 -175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.409 HG21 ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -59.33 -53.37 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 69.9 mt-10 -57.42 -36.16 71.0 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.347 -0.845 . . . . 0.0 112.486 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -71.26 -61.84 1.62 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.078 0.854 . . . . 0.0 113.003 169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -89.14 -20.09 24.69 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -160.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 41' ' ' LEU . 13.9 tp -69.92 88.63 0.57 Allowed 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.063 -1.023 . . . . 0.0 110.566 170.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -9.28 -68.37 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.82 2.048 . . . . 0.0 113.968 154.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -79.76 2.55 73.32 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.729 -1.039 . . . . 0.0 115.671 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 165.15 40.94 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.711 1.756 . . . . 0.0 112.019 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 37' ' ' ILE . 12.5 t80 -73.28 77.3 1.33 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.783 -0.834 . . . . 0.0 111.503 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -144.07 152.95 41.67 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.845 0.858 . . . . 0.0 109.949 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mm -49.12 -47.37 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.694 1.198 . . . . 0.0 109.452 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.84 -53.88 35.33 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.999 0.904 . . . . 0.0 110.424 -174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.06 74.57 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.266 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.03 -59.02 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 121.907 -0.496 . . . . 0.0 109.751 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.0 t -50.67 -54.05 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.999 0.92 . . . . 0.0 108.843 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -51.06 -44.52 61.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.609 0.763 . . . . 0.0 111.638 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.75 -54.45 46.91 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -56.53 -50.85 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -50.94 -66.13 0.44 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.121 0.568 . . . . 0.0 109.55 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -85.77 -29.02 24.17 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.295 0.638 . . . . 0.0 111.891 -158.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.88 140.95 0.73 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -137.93 137.8 38.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -170.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.7 -114.73 3.73 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.2 3.96 54.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.577 0.751 . . . . 0.0 112.722 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.459 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.1 ttt -90.21 133.62 33.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 119.094 0.861 . . . . 0.0 111.32 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.0 148.01 56.13 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.536 2.157 . . . . 0.0 111.385 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.35 154.91 38.81 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.044 1.338 . . . . 0.0 110.955 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -122.16 -0.63 9.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.486 0.714 . . . . 0.0 112.04 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -49.66 138.54 14.05 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.309 0.576 . . . . 0.0 109.514 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.2 -8.99 0.08 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.746 1.641 . . . . 0.0 115.632 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -91.35 -41.92 10.63 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.05 1.925 . . . . 0.0 109.829 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.3 155.17 18.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.685 0.794 . . . . 0.0 109.039 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.69 171.7 13.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.644 0.735 . . . . 0.0 110.49 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.46 -52.46 64.46 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.186 1.394 . . . . 0.0 109.496 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -63.72 -47.21 82.01 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 122.756 1.265 . . . . 0.0 108.81 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -50.37 -61.69 2.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.249 1.82 . . . . 0.0 111.229 175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 mm -46.24 -56.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.072 1.349 . . . . 0.0 109.689 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.04 72.05 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.059 -0.4 . . . . 0.0 111.558 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.32 -48.25 39.09 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -42.89 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 122.493 -0.416 . . . . 0.0 109.973 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.89 -56.49 20.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.299 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.49 -46.57 57.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.004 0.522 . . . . 0.0 112.134 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -53.04 62.34 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.388 0.675 . . . . 0.0 111.236 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.2 t -54.06 -44.06 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -57.9 -50.03 74.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.916 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -57.39 -54.45 46.72 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.938 0.399 . . . . 0.0 110.57 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 18.0 mm100 -48.25 -55.25 11.01 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.86 0.864 . . . . 0.0 110.091 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.92 82.51 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.363 0.665 . . . . 0.0 111.411 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.82 63.87 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 124.075 0.95 . . . . 0.0 111.063 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.47 -10.16 82.2 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 173.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.56 46.79 8.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.399 2.28 . . . . 0.0 110.685 -168.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.74 36.8 1.97 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.596 1.158 . . . . 0.0 111.253 -168.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.404 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 92.6 m95 . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.065 -1.445 . . . . 0.0 109.631 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.459 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.334 2.6 mp0 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.12 -137.77 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.849 1.66 . . . . 0.0 111.075 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -76.41 99.92 5.03 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.02 0.914 . . . . 0.0 109.97 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.12 -26.23 63.86 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.822 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.14 -47.37 18.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp -56.76 -56.34 22.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.12 -44.91 73.99 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -58.13 -54.77 43.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.322 1.061 . . . . 0.0 110.793 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -46.09 44.19 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.966 0.506 . . . . 0.0 111.222 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.63 -54.47 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -48.47 -58.98 3.85 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 125.212 1.405 . . . . 0.0 111.569 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -46.47 -41.29 13.78 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.725 2.01 . . . . 0.0 111.519 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.49 -47.28 6.46 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -101.35 -33.67 9.92 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -159.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 m -111.41 -47.17 3.2 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.375 1.07 . . . . 0.0 109.356 -160.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.4 -32.3 11.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.666 1.186 . . . . 0.0 111.908 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.24 -45.83 1.01 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.924 1.289 . . . . 0.0 112.358 170.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.8 m -106.13 -32.63 8.16 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.447 0.699 . . . . 0.0 111.578 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -110.67 23.91 13.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.519 1.528 . . . . 0.0 113.815 -169.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.24 120.92 0.12 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.243 1.417 . . . . 0.0 112.787 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.01 -109.94 3.05 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.18 35.7 2.39 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 164.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.04 87.42 0.52 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 125.113 1.339 . . . . 0.0 112.096 -160.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -47.05 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.599 1.16 . . . . 0.0 110.314 166.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -74.94 -33.32 61.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.786 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.9 t -66.77 -54.1 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 122.87 0.468 . . . . 0.0 111.204 -172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.0 mt -118.46 90.85 40.06 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -42.97 -40.82 8.78 Favored 'Trans proline' 0 C--N 1.349 0.57 1 C-N-CA 125.654 4.236 . . . . 0.0 116.699 -163.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -89.42 -21.41 23.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.879 1.672 . . . . 0.0 112.421 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -85.08 43.25 0.99 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.06 -1.025 . . . . 0.0 110.399 -171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 p -69.81 169.47 12.97 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.316 2.246 . . . . 0.0 112.308 -169.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.9 28.82 0.17 Allowed 'General case' 0 CA--C 1.541 0.596 0 O-C-N 120.637 -1.29 . . . . 0.0 112.904 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -83.47 162.53 20.92 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -56.53 -61.49 2.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.922 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.04 -33.07 37.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.812 0.845 . . . . 0.0 112.546 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.8 -44.15 33.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.07 -54.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.647 -0.658 . . . . 0.0 112.269 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -71.03 -64.73 0.85 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.589 0.356 . . . . 0.0 111.297 167.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.22 -37.41 20.13 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -161.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 103.36 0.37 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 118.904 0.774 . . . . 0.0 111.58 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -24.95 -68.1 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.828 2.051 . . . . 0.0 113.559 167.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.85 -8.9 87.22 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.552 -1.138 . . . . 0.0 114.698 -176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.49 39.31 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 119.975 1.887 . . . . 0.0 113.121 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -73.74 70.71 1.41 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.313 1.045 . . . . 0.0 111.16 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -147.59 153.14 39.03 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.416 -0.803 . . . . 0.0 111.407 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.8 mm -53.55 -45.85 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.85 1.26 . . . . 0.0 109.116 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -51.65 -59.72 3.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.974 0.909 . . . . 0.0 109.566 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.74 -50.67 60.14 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.824 1.249 . . . . 0.0 111.805 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.6 mm -55.66 -57.25 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 O-C-N 121.746 -0.596 . . . . 0.0 109.976 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 123.416 0.686 . . . . 0.0 109.33 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -50.36 -42.07 52.67 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.771 0.829 . . . . 0.0 111.138 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.85 -57.74 11.71 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.439 0.695 . . . . 0.0 109.764 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.06 -46.69 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.41 1.084 . . . . 0.0 110.427 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.85 -62.58 1.57 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.736 0.814 . . . . 0.0 109.105 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -87.15 -26.84 23.4 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -163.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.15 155.17 5.64 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 118.641 0.655 . . . . 0.0 113.151 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -130.08 -177.26 4.23 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.063 2.145 . . . . 0.0 111.897 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -33.0 -55.65 0.52 Allowed Glycine 0 C--N 1.339 0.698 0 C-N-CA 127.667 2.556 . . . . 0.0 115.396 -171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.1 44.49 2.96 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.039 0.936 . . . . 0.0 109.898 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 8.8 ttt -138.04 116.59 9.65 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.492 1.117 . . . . 0.0 109.333 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -53.48 144.84 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.574 2.182 . . . . 0.0 111.756 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.78 140.94 36.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -110.6 7.04 22.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.793 0.724 . . . . 0.0 111.221 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -46.09 119.36 2.25 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 124.524 1.13 . . . . 0.0 110.856 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.82 7.3 21.63 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.357 0.98 . . . . 0.0 114.976 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -94.26 -39.44 10.52 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 119.194 1.497 . . . . 0.0 109.167 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.3 152.39 20.75 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 168.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.64 168.8 12.34 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.595 0.712 . . . . 0.0 110.041 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -61.61 -47.17 86.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.039 0.936 . . . . 0.0 109.771 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.04 -48.34 76.68 Favored 'General case' 0 CA--C 1.526 0.055 0 CA-C-O 122.533 1.159 . . . . 0.0 109.39 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -51.56 -60.82 2.72 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.854 1.662 . . . . 0.0 110.857 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.68 -57.14 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.485 1.514 . . . . 0.0 109.866 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.28 -39.15 72.2 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.117 -0.364 . . . . 0.0 111.653 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -44.71 40.03 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.62 -45.04 98.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.687 0.744 . . . . 0.0 110.531 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.33 -53.73 53.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 122.258 -0.276 . . . . 0.0 110.507 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.0 -43.31 63.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -60.61 -55.22 35.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.892 0.477 . . . . 0.0 110.509 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.5 t -52.64 -44.34 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 122.963 0.505 . . . . 0.0 109.821 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -60.02 -49.82 76.16 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 122.133 -0.355 . . . . 0.0 111.559 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -60.98 -46.54 90.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.782 0.833 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -51.85 -61.42 2.27 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.628 173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.5 94.43 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.463 0.705 . . . . 0.0 111.892 -174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.59 69.05 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.296 1.039 . . . . 0.0 111.068 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 12.1 67.42 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 119.184 -0.786 . . . . 0.0 111.989 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 24.88 54.31 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.898 2.479 . . . . 0.0 112.963 -164.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -103.43 36.68 2.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.514 1.125 . . . . 0.0 111.31 -167.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.974 166.887 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.417 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.761 -0.161 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.57 45.36 25.05 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.066 0.946 . . . . 0.0 110.116 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -71.91 147.22 47.25 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.346 1.069 . . . . 0.0 111.183 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mp -67.4 -47.88 68.98 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.264 2.226 . . . . 0.0 110.86 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.0 -45.9 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.64 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -51.4 -55.7 17.17 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.797 1.239 . . . . 0.0 109.108 168.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.12 -44.3 42.41 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -62.83 -57.05 12.21 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 121.728 -0.866 . . . . 0.0 110.17 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -46.0 14.47 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.45 0.7 . . . . 0.0 111.252 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.03 -58.13 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -46.53 -60.42 2.38 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.898 1.279 . . . . 0.0 111.797 -176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.2 -29.63 58.3 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.7 1.6 . . . . 0.0 111.533 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.49 -46.26 5.55 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.77 0.714 . . . . 0.0 111.955 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -105.0 -37.23 7.04 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 123.915 0.886 . . . . 0.0 112.23 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 m -104.06 -42.6 5.5 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.357 1.063 . . . . 0.0 109.106 -163.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.72 -35.34 4.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.117 1.367 . . . . 0.0 112.32 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.31 -45.42 2.12 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.71 1.204 . . . . 0.0 112.454 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.08 -33.83 7.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 111.231 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -113.92 15.57 18.5 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 117.399 -1.286 . . . . 0.0 114.33 -168.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 6.49 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.008 2.123 . . . . 0.0 116.052 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.43 58.63 0.38 Allowed Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.14 55.43 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.179 0.895 . . . . 0.0 112.21 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.62 82.21 0.76 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 125.174 1.369 . . . . 0.0 110.993 -162.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -52.25 92.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.288 1.035 . . . . 0.0 111.493 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -82.14 -0.71 46.08 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.047 0.84 . . . . 0.0 112.889 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.14 -55.34 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-N 118.47 0.577 . . . . 0.0 109.891 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.6 mt -111.69 90.97 13.65 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -38.18 -50.92 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 1 C-N-CA 125.999 4.466 . . . . 0.0 116.639 -164.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.17 -15.69 49.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.149 0.579 . . . . 0.0 112.282 -169.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -85.34 55.21 3.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.127 -0.983 . . . . 0.0 109.526 -171.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.7 p -80.64 152.08 28.68 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.004 1.722 . . . . 0.0 111.37 -170.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.72 37.93 0.19 Allowed 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.761 -0.587 . . . . 0.0 112.545 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -116.95 139.22 50.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 120.036 1.289 . . . . 0.0 110.405 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -29.04 -68.58 0.07 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 126.596 1.959 . . . . 0.0 112.217 -169.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.41 -51.57 3.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.248 1.019 . . . . 0.0 112.513 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.6 -39.92 61.89 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.569 0.747 . . . . 0.0 109.937 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.99 -47.82 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.36 -34.8 75.89 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.724 0.81 . . . . 0.0 112.493 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.13 -58.98 3.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 119.223 0.92 . . . . 0.0 111.0 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -86.35 -40.95 14.93 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -160.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.92 123.42 12.46 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 118.932 0.787 . . . . 0.0 112.872 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.04 -38.6 57.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.117 1.767 . . . . 0.0 111.483 -168.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.22 27.7 9.3 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.212 0.91 . . . . 0.0 113.06 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.48 177.44 22.57 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.971 1.386 . . . . 0.0 111.766 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -71.22 75.86 0.71 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.464 -0.433 . . . . 0.0 111.006 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -135.37 147.47 49.08 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.229 1.012 . . . . 0.0 109.262 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.58 -50.76 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -39.4 -58.95 1.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.078 1.751 . . . . 0.0 110.585 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.6 -50.39 72.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.97 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.0 mm -53.57 -59.64 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 O-C-N 121.781 -0.574 . . . . 0.0 109.936 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.3 t -50.47 -52.48 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 124.584 1.153 . . . . 0.0 109.524 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -50.05 -42.96 50.75 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.171 0.989 . . . . 0.0 111.082 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -59.31 5.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.669 0.788 . . . . 0.0 109.45 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mp -55.51 -48.21 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.533 1.133 . . . . 0.0 110.192 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.25 -64.9 0.69 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.451 0.7 . . . . 0.0 109.425 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -84.17 -23.33 30.64 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -163.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.16 160.7 22.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.348 0.522 . . . . 0.0 111.948 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.03 -176.31 5.6 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.625 1.17 . . . . 0.0 112.327 -158.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -45.8 120.09 4.19 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.14 46.48 0.09 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.847 2.059 . . . . 0.0 113.493 -170.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.409 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 12.0 ttt -140.27 111.14 7.1 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 124.02 0.928 . . . . 0.0 110.304 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -49.46 142.53 23.02 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.455 2.77 . . . . 0.0 112.774 172.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.39 141.97 43.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -112.38 5.71 18.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.786 0.721 . . . . 0.0 111.326 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -44.81 121.29 2.66 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 124.679 1.191 . . . . 0.0 110.477 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.37 -16.44 1.26 Allowed Glycine 0 CA--C 1.535 1.303 0 CA-C-O 119.142 -0.81 . . . . 0.0 114.873 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.71 -38.21 54.74 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.42 1.61 . . . . 0.0 109.315 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.02 149.38 25.84 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.31 169.7 10.09 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 110.023 172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -61.83 -48.69 79.45 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.152 0.981 . . . . 0.0 109.859 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -65.4 -45.03 85.56 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 122.165 0.983 . . . . 0.0 108.988 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -54.27 -60.08 3.81 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.26 1.824 . . . . 0.0 111.097 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 mm -43.7 -56.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.373 1.469 . . . . 0.0 109.708 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.29 70.43 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.83 -0.544 . . . . 0.0 111.625 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.4 -48.66 29.25 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.801 -1.719 . . . . 0.0 108.801 -176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -43.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.08 25.85 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.691 173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.05 -48.51 64.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.903 0.481 . . . . 0.0 111.99 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.39 -55.19 38.26 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.617 0.767 . . . . 0.0 110.682 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 t -50.22 -46.94 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -56.53 -53.62 55.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.903 0.319 . . . . 0.0 110.986 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -54.8 -59.18 5.08 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 122.739 1.257 . . . . 0.0 111.255 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -53.11 -43.78 67.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.177 2.591 . . . . 0.0 110.067 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.15 -48.29 44.62 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.119 1.367 . . . . 0.0 112.208 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.69 63.72 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.652 1.181 . . . . 0.0 110.633 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.24 3.44 72.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.811 -0.994 . . . . 0.0 112.874 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.16 56.74 1.67 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.274 1.43 . . . . 0.0 110.504 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -89.28 12.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.273 0.629 . . . . 0.0 111.143 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 64.3 m95 . . . . . 0 C--O 1.253 1.241 0 CA-C-O 116.767 -1.587 . . . . 0.0 109.136 172.841 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.409 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.82 60.63 0.37 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.846 1.258 . . . . 0.0 111.58 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -77.11 152.15 35.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.444 1.098 . . . . 0.0 110.869 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.8 mt -75.07 -37.07 61.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.312 1.445 . . . . 0.0 110.039 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.76 64.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.018 0.826 . . . . 0.0 110.361 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.8 tp -51.26 -57.9 7.61 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.423 1.089 . . . . 0.0 108.629 168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.53 -44.49 46.36 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -59.3 -56.23 24.76 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.013 0.906 . . . . 0.0 110.399 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.04 -45.51 42.89 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.361 0.665 . . . . 0.0 111.091 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.77 -55.94 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -47.48 -59.32 3.32 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.22 1.408 . . . . 0.0 111.616 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -46.08 -40.46 10.83 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.31 2.244 . . . . 0.0 111.514 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.0 -44.76 6.58 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -103.51 -36.07 8.1 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 123.541 0.736 . . . . 0.0 112.586 -159.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 m -108.31 -42.56 4.57 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.559 1.144 . . . . 0.0 109.316 -162.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -36.76 2.97 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.082 1.353 . . . . 0.0 112.016 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.32 -46.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.259 1.424 . . . . 0.0 112.901 172.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.3 m -111.61 -22.2 11.34 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.681 0.793 . . . . 0.0 111.782 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -122.55 15.99 10.37 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 5.32 -82.86 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.164 2.185 . . . . 0.0 116.043 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.33 57.5 0.42 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.201 0.905 . . . . 0.0 110.973 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.05 14.23 63.24 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.904 0.764 . . . . 0.0 111.897 -168.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.17 84.13 0.49 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 125.067 1.318 . . . . 0.0 111.368 -160.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -48.4 107.37 0.13 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.993 0.917 . . . . 0.0 111.351 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -23.82 45.06 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.036 0.534 . . . . 0.0 110.907 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.1 t -83.64 -53.73 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.498 0.59 . . . . 0.0 109.827 -172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 mt -116.27 94.52 42.62 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -41.29 -48.3 5.21 Favored 'Trans proline' 0 C--N 1.348 0.502 1 C-N-CA 125.488 4.125 . . . . 0.0 115.909 -165.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -84.8 -16.13 42.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.76 1.624 . . . . 0.0 112.267 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -85.0 52.07 2.34 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.148 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 p -75.33 166.14 24.08 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 127.097 2.159 . . . . 0.0 111.275 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.19 44.83 0.6 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.221 -0.925 . . . . 0.0 111.64 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -94.1 149.72 20.98 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.804 1.242 . . . . 0.0 109.252 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -49.88 -60.11 3.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.01 59.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.588 0.755 . . . . 0.0 112.565 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.47 -42.97 33.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -53.92 -56.07 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 168.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -61.05 -32.43 72.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.156 0.434 . . . . 0.0 112.133 -169.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -71.75 -64.65 0.89 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.588 0.355 . . . . 0.0 111.24 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -83.21 -40.47 19.61 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -161.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.89 117.3 5.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.138 0.881 . . . . 0.0 111.321 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -66.83 65.79 0.06 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.104 1.762 . . . . 0.0 109.776 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.65 -38.84 0.14 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.8 0.714 . . . . 0.0 113.09 -169.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.2 177.8 45.94 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 118.476 1.138 . . . . 0.0 112.205 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -75.08 72.76 2.22 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.219 0.608 . . . . 0.0 111.734 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -140.02 152.04 45.94 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.02 0.928 . . . . 0.0 109.725 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 mm -53.79 -45.56 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.977 0.911 . . . . 0.0 108.637 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.6 mp0 -48.32 -61.39 2.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.479 1.111 . . . . 0.0 110.061 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -48.49 -49.61 35.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.943 1.297 . . . . 0.0 112.428 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.1 mm -56.83 -59.65 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 121.894 -0.504 . . . . 0.0 109.71 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.39 -52.03 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 124.073 0.949 . . . . 0.0 109.032 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -48.46 -48.25 37.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.593 1.557 . . . . 0.0 112.204 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -58.69 -55.14 38.88 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.23 0.923 . . . . 0.0 109.549 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.91 -44.47 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.561 0.745 . . . . 0.0 111.262 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -56.41 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.2 1.0 . . . . 0.0 109.731 -176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -89.68 -21.23 22.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.06 0.944 . . . . 0.0 113.239 -166.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.72 143.97 0.74 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.227 0.921 . . . . 0.0 112.465 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.78 -176.47 3.4 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.614 1.166 . . . . 0.0 109.13 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 23.29 -92.9 0.01 OUTLIER Glycine 0 CA--C 1.527 0.842 0 C-N-CA 127.644 2.545 . . . . 0.0 116.01 169.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.79 31.05 5.57 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.76 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.0 ttt -116.93 122.22 31.67 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.671 1.189 . . . . 0.0 109.336 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.35 142.62 50.26 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.703 1.602 . . . . 0.0 110.478 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.63 154.25 18.13 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.393 1.077 . . . . 0.0 110.627 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -119.39 0.19 11.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.284 0.634 . . . . 0.0 111.849 171.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -44.99 131.2 7.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.092 0.957 . . . . 0.0 109.904 166.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.03 -6.33 0.72 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.112 1.339 . . . . 0.0 114.997 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -94.1 -42.14 9.16 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.637 1.718 . . . . 0.0 109.389 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.16 154.01 19.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.581 0.752 . . . . 0.0 109.109 172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.44 168.64 15.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.511 0.672 . . . . 0.0 110.024 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -62.18 -46.92 86.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.891 0.876 . . . . 0.0 109.718 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.6 -45.66 85.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 122.457 1.122 . . . . 0.0 109.289 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -55.41 -60.47 3.37 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.387 1.875 . . . . 0.0 110.8 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 mm -42.73 -56.86 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 125.304 1.442 . . . . 0.0 109.636 171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.65 72.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.712 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.32 49.19 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -42.31 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 O-C-N 122.454 -0.439 . . . . 0.0 110.296 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.11 -57.37 11.35 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.784 0.266 . . . . 0.0 111.351 170.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.16 -47.15 62.18 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.773 0.429 . . . . 0.0 111.934 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -58.54 -54.18 49.99 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.402 0.681 . . . . 0.0 111.382 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -54.48 -44.48 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -58.1 -49.69 76.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.795 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -55.96 -54.44 44.71 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 122.686 0.394 . . . . 0.0 110.621 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 28.9 mm100 -48.1 -53.76 15.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.78 0.832 . . . . 0.0 110.497 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.2 91.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.12 0.568 . . . . 0.0 112.455 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.29 -58.62 5.46 Favored 'General case' 0 C--O 1.228 -0.06 0 C-N-CA 124.322 1.049 . . . . 0.0 110.867 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.49 68.02 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.7 42.37 1.46 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.688 1.995 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.79 34.85 3.34 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.982 1.313 . . . . 0.0 111.602 -168.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 86.3 m95 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.999 -1.477 . . . . 0.0 109.4 162.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.444 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 18.5 mp0 . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.96 42.35 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.981 0.912 . . . . 0.0 111.518 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -70.14 147.4 49.96 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.052 0.929 . . . . 0.0 110.853 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -49.41 60.78 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 127.547 2.339 . . . . 0.0 110.774 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.29 -46.64 76.27 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.64 -53.45 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.534 0.734 . . . . 0.0 109.795 169.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.79 -45.23 31.35 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -61.79 -56.15 22.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 121.682 -0.893 . . . . 0.0 110.339 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.47 -47.08 13.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.289 0.636 . . . . 0.0 111.355 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.73 -55.79 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 173.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -47.31 -60.08 2.74 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 124.647 1.179 . . . . 0.0 111.863 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -32.6 48.17 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.701 1.6 . . . . 0.0 111.516 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.56 -47.73 5.28 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.731 0.696 . . . . 0.0 111.731 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -101.2 -36.28 8.99 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 123.832 0.853 . . . . 0.0 112.259 -160.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.0 -45.47 4.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.312 1.045 . . . . 0.0 109.404 -162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.77 -32.92 9.37 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.376 1.07 . . . . 0.0 112.087 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.85 -46.18 1.93 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.844 1.257 . . . . 0.0 112.386 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -107.27 -21.61 12.89 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.931 0.893 . . . . 0.0 111.32 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -125.38 31.2 5.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.01 123.48 4.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.906 1.23 . . . . 0.0 110.742 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.87 83.55 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.839 -0.538 . . . . 0.0 112.415 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.9 9.07 55.68 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.697 -0.884 . . . . 0.0 112.456 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 82.86 0.92 Allowed Glycine 0 C--N 1.335 0.477 0 CA-C-N 118.081 0.94 . . . . 0.0 111.589 -158.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -40.33 105.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.962 1.305 . . . . 0.0 112.493 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -8.55 59.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.138 0.975 . . . . 0.0 111.325 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.93 -54.03 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 O-C-N 121.261 -0.9 . . . . 0.0 109.307 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.3 mt -117.26 92.84 41.1 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -40.06 -43.53 3.65 Favored 'Trans proline' 0 C--N 1.347 0.479 1 C-N-CA 125.514 4.143 . . . . 0.0 115.861 -171.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -81.56 -25.77 35.55 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.707 0.803 . . . . 0.0 112.14 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -84.31 53.41 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.815 -1.178 . . . . 0.0 109.425 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.5 p -74.67 174.46 9.07 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.915 1.286 . . . . 0.0 111.524 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.4 22.36 1.55 Allowed 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.058 -0.401 . . . . 0.0 111.525 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.74 153.75 42.48 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.809 1.186 . . . . 0.0 109.216 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -52.83 -59.35 4.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.668 0.747 . . . . 0.0 109.588 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.39 -38.83 44.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.632 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.64 -42.46 58.51 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -171.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -50.73 -54.38 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 164.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -61.3 -34.25 74.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -69.55 -59.82 2.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.949 0.795 . . . . 0.0 111.56 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -86.95 -36.89 18.05 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -161.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.06 104.56 3.05 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.325 0.511 . . . . 0.0 111.953 176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -32.96 -52.55 0.34 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.276 1.831 . . . . 0.0 112.68 162.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.11 -6.78 75.23 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 119.319 -0.712 . . . . 0.0 114.199 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.43 -177.62 46.11 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.293 1.547 . . . . 0.0 111.788 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -72.76 70.58 0.98 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.301 0.64 . . . . 0.0 110.598 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -134.08 152.76 51.98 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.543 1.137 . . . . 0.0 109.457 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.0 -51.79 62.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -39.12 -57.97 1.22 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 110.37 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.24 70.29 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.955 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.3 mm -57.37 -57.83 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.669 -0.644 . . . . 0.0 109.546 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.8 t -50.98 -51.99 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.485 0.584 . . . . 0.0 109.931 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -44.02 -51.31 7.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.565 1.546 . . . . 0.0 111.558 173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -59.54 -52.96 63.31 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.87 -48.27 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.261 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.74 -74.53 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.472 0.709 . . . . 0.0 109.627 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.13 15.67 27.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -158.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 32.64 116.7 0.0 OUTLIER Glycine 0 C--N 1.342 0.892 0 C-N-CA 128.691 3.043 . . . . 0.0 118.116 162.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.33 175.16 7.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.411 -0.895 . . . . 0.0 111.265 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 5.31 -87.23 0.0 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 127.843 2.64 . . . . 0.0 116.141 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.86 33.75 4.23 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.801 0.841 . . . . 0.0 112.236 -174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.3 ttt -115.11 127.79 26.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.375 1.47 . . . . 0.0 108.578 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.39 -26.64 36.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.014 3.143 . . . . 0.0 117.468 -171.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.3 141.29 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.237 1.415 . . . . 0.0 110.46 -168.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -121.04 10.87 10.86 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.366 -0.834 . . . . 0.0 111.62 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -45.92 116.52 1.24 Allowed 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 125.238 1.415 . . . . 0.0 110.604 171.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.52 17.05 56.4 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.561 1.077 . . . . 0.0 114.434 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -104.71 -38.02 6.86 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.792 1.296 . . . . 0.0 109.862 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -101.25 155.64 17.91 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.85 169.17 13.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.525 0.679 . . . . 0.0 110.115 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.23 -47.98 80.16 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.974 0.91 . . . . 0.0 109.855 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 8.9 t0 -63.5 -47.06 83.26 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 108.514 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -52.69 -61.85 2.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.258 1.823 . . . . 0.0 111.586 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.8 mm -43.42 -56.29 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.64 1.576 . . . . 0.0 109.584 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.39 -36.62 73.81 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 122.036 -0.415 . . . . 0.0 111.81 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.06 -48.46 26.23 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.54 -42.0 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -57.49 12.33 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.008 0.367 . . . . 0.0 111.458 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.29 -47.65 55.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 112.117 177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -60.07 -55.05 38.66 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 122.949 0.5 . . . . 0.0 110.891 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.8 t -48.95 -45.84 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -57.78 -54.84 42.36 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 119.237 -0.411 . . . . 0.0 111.255 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -52.67 -53.73 43.29 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 123.225 1.488 . . . . 0.0 111.13 176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -61.01 -39.29 89.18 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.385 2.274 . . . . 0.0 109.837 -170.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.23 -35.97 27.67 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 125.942 1.697 . . . . 0.0 112.341 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.68 -55.71 29.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.287 0.948 . . . . 0.0 110.022 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.02 -18.01 74.2 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 170.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 54.55 39.22 30.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.537 1.935 . . . . 0.0 110.293 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 38.68 0.99 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.525 1.13 . . . . 0.0 110.11 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 78.7 m95 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 116.615 -1.659 . . . . 0.0 110.702 174.32 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 43.77 25.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.081 0.855 . . . . 0.0 109.91 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.49 152.97 42.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.859 0.838 . . . . 0.0 111.02 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.3 mt -75.53 -36.99 60.36 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.491 1.516 . . . . 0.0 110.24 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.8 -44.85 63.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.932 0.787 . . . . 0.0 110.278 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -49.98 -57.83 6.73 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.571 1.148 . . . . 0.0 108.67 166.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.08 -46.36 33.43 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' NZ ' ' OD2' ' A' ' 12' ' ' ASP . 28.4 tttm -59.51 -55.41 34.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 118.03 0.915 . . . . 0.0 110.632 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.01 -46.09 43.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.318 0.647 . . . . 0.0 111.011 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 72' ' ' GLU . 88.3 t -59.14 -55.96 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -48.12 -59.69 3.2 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.234 1.414 . . . . 0.0 111.555 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' NZ ' ' A' ' 8' ' ' LYS . 34.5 m-20 -46.45 -41.08 13.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.101 2.16 . . . . 0.0 111.262 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.48 -44.28 7.0 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.716 -0.553 . . . . 0.0 111.716 -176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -103.93 -36.99 7.58 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.47 0.708 . . . . 0.0 112.425 -159.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 m -106.79 -43.62 4.64 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.248 1.019 . . . . 0.0 109.134 -162.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.33 -31.63 6.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.699 1.2 . . . . 0.0 112.542 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.29 -46.56 1.58 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.675 1.19 . . . . 0.0 112.32 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.8 m -106.72 -28.22 10.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 111.038 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' CE1' HD21 ' A' ' 32' ' ' LEU . 99.3 m-70 -117.31 33.59 5.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.07 1.348 . . . . 0.0 113.159 -170.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.86 118.19 1.37 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.789 1.177 . . . . 0.0 110.956 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.41 41.59 95.3 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.925 -0.485 . . . . 0.0 112.341 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.9 40.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.974 0.797 . . . . 0.0 112.464 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.23 86.64 1.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -161.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -43.07 103.52 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.79 1.236 . . . . 0.0 110.913 170.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.0 -40.33 63.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.84 -50.51 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 122.917 0.487 . . . . 0.0 111.075 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 mt -121.79 87.15 46.19 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -37.87 -48.36 2.1 Favored 'Trans proline' 0 C--N 1.347 0.452 1 C-N-CA 126.145 4.564 . . . . 0.0 116.902 -165.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -82.99 -19.41 37.08 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.477 1.511 . . . . 0.0 112.465 -172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.42 43.42 0.96 Allowed 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.225 -0.922 . . . . 0.0 110.614 -170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.1 p -70.36 162.92 27.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.076 0.951 . . . . 0.0 111.974 -167.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 19' ' ' HIS . 28.2 mt -75.6 41.05 0.19 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -122.75 149.27 44.32 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 119.926 1.239 . . . . 0.0 111.26 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -36.88 -63.61 0.41 Allowed 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.621 1.569 . . . . 0.0 112.013 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.53 -31.22 34.48 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.14 -44.0 12.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.845 0.748 . . . . 0.0 109.835 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -51.17 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.523 0.729 . . . . 0.0 110.177 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.84 -29.13 69.32 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.319 -0.863 . . . . 0.0 112.808 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -77.58 -59.43 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.847 0.459 . . . . 0.0 111.006 172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -80.82 -39.76 26.1 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -166.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.94 102.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.801 0.728 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -33.0 -63.34 0.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.876 1.67 . . . . 0.0 112.778 166.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.55 -4.36 45.24 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.405 1.003 . . . . 0.0 114.933 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.94 176.62 50.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 119.647 1.724 . . . . 0.0 111.257 173.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -73.51 72.78 1.4 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.278 -0.542 . . . . 0.0 110.268 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -133.85 144.57 49.02 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.431 1.092 . . . . 0.0 108.681 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.3 mm -61.79 -49.73 83.09 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.72 -58.96 1.81 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.121 1.768 . . . . 0.0 110.321 172.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.46 -49.56 72.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.938 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mm -55.95 -58.79 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 O-C-N 121.788 -0.57 . . . . 0.0 109.547 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.14 -49.69 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 123.716 0.806 . . . . 0.0 109.804 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -51.32 -43.47 61.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.986 0.914 . . . . 0.0 111.847 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -60.17 -54.73 42.35 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.66 -49.44 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.959 0.503 . . . . 0.0 110.599 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -50.04 -68.91 0.13 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 123.286 0.635 . . . . 0.0 109.665 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -89.45 -20.21 24.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.157 0.583 . . . . 0.0 112.331 -153.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.38 157.7 15.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -143.86 -167.87 2.71 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.758 1.223 . . . . 0.0 111.969 -163.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -39.11 -55.96 2.31 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.129 1.823 . . . . 0.0 114.453 -162.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.2 49.97 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.427 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.7 ttt -135.23 121.17 14.23 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 123.935 0.894 . . . . 0.0 109.698 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.39 149.53 69.35 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.07 1.847 . . . . 0.0 111.176 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.4 152.46 45.03 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.537 1.135 . . . . 0.0 110.343 172.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -120.36 -0.16 10.45 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.788 0.835 . . . . 0.0 111.498 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -48.86 136.07 14.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.316 0.579 . . . . 0.0 109.584 168.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.39 2.75 1.14 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.822 1.677 . . . . 0.0 115.358 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -99.84 -43.2 6.5 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 119.885 1.843 . . . . 0.0 109.545 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.5 mt -101.53 157.13 17.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.538 0.735 . . . . 0.0 109.19 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.84 168.5 16.65 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.756 0.788 . . . . 0.0 109.98 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.38 -49.7 74.51 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.291 1.037 . . . . 0.0 109.777 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.63 -40.84 80.14 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-O 122.016 0.912 . . . . 0.0 109.415 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HG3' HG21 ' A' ' 10' ' ' VAL . 54.3 tt0 -53.44 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.704 1.602 . . . . 0.0 110.734 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mm -44.07 -56.67 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.11 1.364 . . . . 0.0 109.932 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.98 72.08 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.885 -0.509 . . . . 0.0 111.627 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.76 -46.27 39.32 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -43.46 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 O-C-N 122.413 -0.463 . . . . 0.0 109.947 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.62 -55.78 29.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.211 -0.306 . . . . 0.0 111.348 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.81 -47.06 60.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.047 0.539 . . . . 0.0 112.21 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.41 -51.3 70.09 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.684 0.793 . . . . 0.0 111.115 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -54.24 -43.85 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.55 -50.33 74.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.617 0.367 . . . . 0.0 110.889 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.86 -56.28 19.07 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.589 0.756 . . . . 0.0 110.435 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 15.4 mm100 -50.78 -53.03 35.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.67 0.788 . . . . 0.0 110.273 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.24 1.016 . . . . 0.0 111.72 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -52.76 63.39 Favored 'General case' 0 CA--C 1.524 -0.049 0 C-N-CA 124.254 1.022 . . . . 0.0 110.304 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -65.52 -25.46 71.48 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 172.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 40.65 19.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.477 1.911 . . . . 0.0 108.745 -170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -101.05 37.15 1.81 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.107 1.363 . . . . 0.0 110.308 -167.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.403 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 93.7 m95 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.48 166.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.427 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.65 -157.16 0.55 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 129.701 3.2 . . . . 0.0 104.059 170.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -78.38 77.98 4.86 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.344 1.884 . . . . 0.0 107.929 169.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.5 mt -69.33 -26.67 64.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.911 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.13 -51.96 47.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.114 0.565 . . . . 0.0 110.507 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.81 -56.25 24.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.72 -44.38 69.66 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.3 tttm -58.16 -55.73 31.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 118.326 1.063 . . . . 0.0 110.479 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.85 -45.28 50.26 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.521 0.6 . . . . 0.0 111.3 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -55.48 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -49.05 -58.47 4.87 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.318 1.447 . . . . 0.0 111.689 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -43.73 -43.41 5.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.322 2.249 . . . . 0.0 111.507 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.49 -43.5 7.86 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -106.22 -33.96 7.65 Favored 'General case' 0 C--O 1.23 0.059 0 C-N-CA 123.403 0.681 . . . . 0.0 112.782 -158.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.9 m -112.02 -44.31 3.45 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.489 1.116 . . . . 0.0 109.573 -161.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.0 -34.34 3.96 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.961 1.704 . . . . 0.0 112.427 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.07 -44.0 1.69 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.603 1.161 . . . . 0.0 112.401 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.33 -31.2 7.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.162 0.985 . . . . 0.0 111.056 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -112.64 15.96 19.84 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.14 1.376 . . . . 0.0 114.244 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.51 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.77 2.428 . . . . 0.0 116.751 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.33 56.73 0.59 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.326 0.965 . . . . 0.0 111.047 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.56 15.2 72.96 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 123.761 0.696 . . . . 0.0 111.477 -167.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -106.26 85.27 0.43 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 125.727 1.632 . . . . 0.0 111.119 -162.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -43.93 112.01 0.35 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.684 1.194 . . . . 0.0 111.058 168.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -83.77 -33.08 25.09 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.905 0.482 . . . . 0.0 110.275 171.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.01 -69.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.057 0.543 . . . . 0.0 111.786 -164.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 mt -97.72 97.78 4.52 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 169.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.9 -33.69 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.222 2.615 . . . . 0.0 113.592 -151.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -81.47 -18.79 43.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.592 1.557 . . . . 0.0 112.025 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.41 40.37 0.36 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 111.034 -177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -64.66 159.58 21.73 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.486 1.114 . . . . 0.0 111.842 -172.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.35 40.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.34 -0.85 . . . . 0.0 111.259 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -98.6 140.13 33.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -42.15 -59.89 1.63 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.654 0.782 . . . . 0.0 110.364 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.29 -49.06 62.02 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.254 0.549 . . . . 0.0 111.454 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.64 87.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.28 0.632 . . . . 0.0 109.886 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.42 -54.69 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 123.357 0.663 . . . . 0.0 109.334 173.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -59.93 -35.51 75.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.303 -0.873 . . . . 0.0 112.071 -172.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -70.62 -59.89 2.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.629 0.649 . . . . 0.0 112.649 168.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -90.57 -32.92 16.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -159.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.28 107.29 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.843 0.857 . . . . 0.0 112.574 -175.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -50.34 81.27 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.593 1.957 . . . . 0.0 109.925 157.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.26 -13.8 4.6 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 127.074 2.273 . . . . 0.0 115.134 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.26 50.72 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.578 1.689 . . . . 0.0 111.092 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.03 69.92 1.5 Allowed 'General case' 0 CA--C 1.533 0.295 0 O-C-N 122.199 -0.589 . . . . 0.0 111.075 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -129.55 144.87 51.46 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.637 1.175 . . . . 0.0 108.429 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.45 -52.48 57.54 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -36.68 -58.79 0.72 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.649 1.98 . . . . 0.0 110.635 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.17 -44.74 75.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.357 1.063 . . . . 0.0 112.674 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.2 mm -60.45 -54.53 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 O-C-N 121.68 -0.637 . . . . 0.0 109.58 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.5 t -54.48 -53.36 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 118.515 0.598 . . . . 0.0 109.678 -176.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -42.98 -46.67 5.54 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.213 1.405 . . . . 0.0 110.971 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -62.93 1.39 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.524 0.73 . . . . 0.0 109.44 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -53.47 -49.23 55.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 125.549 1.539 . . . . 0.0 111.148 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -52.21 -65.24 0.59 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -87.93 -24.39 23.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 123.942 0.776 . . . . 0.0 112.436 -155.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 143.94 3.71 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -129.71 -168.41 1.95 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.585 1.554 . . . . 0.0 111.146 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -44.66 121.58 4.3 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 35.86 43.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.871 2.069 . . . . 0.0 113.711 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 ttt -139.06 109.3 7.62 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.943 0.897 . . . . 0.0 109.739 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.27 145.13 28.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.311 2.674 . . . . 0.0 112.665 174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.73 152.19 39.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 163.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -121.29 -0.75 9.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.482 0.713 . . . . 0.0 111.511 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -47.53 130.85 14.09 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.177 0.591 . . . . 0.0 109.732 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.38 -2.59 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.153 1.359 . . . . 0.0 115.052 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -95.27 -42.52 8.5 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.583 1.692 . . . . 0.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 69.6 mt -101.6 155.92 17.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -70.61 168.2 16.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.622 0.725 . . . . 0.0 110.193 173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -61.97 -47.68 83.75 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.057 0.943 . . . . 0.0 109.643 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.34 -50.12 71.22 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.435 1.112 . . . . 0.0 108.982 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -49.06 -61.83 1.86 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.227 1.811 . . . . 0.0 111.208 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mm -44.89 -56.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 125.41 1.484 . . . . 0.0 109.842 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.74 -42.33 79.1 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 122.205 -0.309 . . . . 0.0 111.645 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -39.82 42.59 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -42.47 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 118.45 1.125 . . . . 0.0 111.134 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.09 -57.5 12.59 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 121.838 -0.539 . . . . 0.0 110.247 173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.02 -40.43 61.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.065 0.546 . . . . 0.0 111.735 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -58.82 -59.59 5.19 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 123.394 0.678 . . . . 0.0 110.659 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.4 t -50.93 -47.89 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.17 -49.8 70.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.283 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -66.24 -48.71 69.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.986 0.914 . . . . 0.0 110.488 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -48.72 -52.39 23.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.212 1.005 . . . . 0.0 110.42 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.82 -57.4 13.06 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 123.617 0.573 . . . . 0.0 110.997 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.66 -54.56 31.71 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.942 1.297 . . . . 0.0 111.463 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.1 -7.19 87.69 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.239 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.74 52.47 13.96 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.474 1.11 . . . . 0.0 109.633 -169.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -110.33 22.14 15.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.772 0.829 . . . . 0.0 110.745 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 75.9 m95 . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.726 -1.607 . . . . 0.0 108.626 151.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 140.94 78.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.74 2.816 . . . . 0.0 111.144 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -76.89 139.89 40.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 110.789 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.4 mt -75.37 -35.42 61.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.753 1.221 . . . . 0.0 110.742 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.09 -44.85 59.87 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 119.022 0.828 . . . . 0.0 109.95 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -54.15 -51.86 62.95 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 167.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.55 -48.04 22.77 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -60.35 -56.43 21.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.763 -0.845 . . . . 0.0 110.656 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.77 -46.11 40.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 111.211 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 72' ' ' GLU . 99.6 t -58.87 -56.98 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -46.65 -61.63 1.74 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.573 1.149 . . . . 0.0 111.246 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -44.68 -42.42 7.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.138 2.175 . . . . 0.0 111.633 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.04 -43.3 6.38 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.924 -0.485 . . . . 0.0 112.172 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -104.01 -36.69 7.65 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.984 0.914 . . . . 0.0 111.939 -159.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 32.6 m -105.69 -46.64 4.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.984 0.914 . . . . 0.0 108.703 -163.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -32.29 8.07 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.702 1.201 . . . . 0.0 112.012 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.75 -46.35 1.24 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.911 1.285 . . . . 0.0 112.355 170.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.7 m -106.35 -28.07 10.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.687 0.795 . . . . 0.0 111.051 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -117.63 32.8 5.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.719 1.207 . . . . 0.0 113.633 -170.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.48 124.42 4.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.837 1.199 . . . . 0.0 110.866 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.16 30.65 74.35 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.789 -0.57 . . . . 0.0 112.834 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.9 19.56 67.73 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.603 -0.939 . . . . 0.0 111.733 -171.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.11 93.38 1.14 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.271 0.938 . . . . 0.0 110.978 -166.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -50.35 116.85 2.07 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.299 0.639 . . . . 0.0 110.916 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -88.26 -12.68 42.97 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.382 0.673 . . . . 0.0 111.752 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.55 -62.44 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.5 mt -106.23 91.84 6.08 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 -34.89 99.26 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.249 2.632 . . . . 0.0 114.401 -155.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.64 -23.95 49.62 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.026 0.53 . . . . 0.0 112.012 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -84.78 56.41 3.87 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.0 -1.063 . . . . 0.0 109.73 -171.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -74.94 164.84 26.13 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.003 1.721 . . . . 0.0 111.62 -173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -81.65 20.46 0.92 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.499 -0.75 . . . . 0.0 111.699 171.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.67 157.95 35.16 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -55.71 -59.38 4.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.565 -176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.79 -45.89 50.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.363 177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.4 91.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -57.01 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.398 170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HG2' ' HB2' ' A' ' 45' ' ' PHE . 96.9 mt-10 -58.01 -37.54 74.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.023 -0.423 . . . . 0.0 112.058 -174.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -74.04 -62.1 1.62 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.442 0.565 . . . . 0.0 111.97 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -80.69 -34.26 34.81 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -161.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 113.0 1.93 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.537 1.062 . . . . 0.0 111.156 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.76 70.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.192 2.197 . . . . 0.0 109.419 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.17 -29.01 0.4 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.761 1.172 . . . . 0.0 112.601 -165.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.37 177.75 51.33 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 118.565 1.183 . . . . 0.0 110.298 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 10.9 t80 -73.79 75.92 1.59 Allowed 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.28 -0.541 . . . . 0.0 110.617 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -134.09 147.19 50.84 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.258 1.023 . . . . 0.0 108.716 -175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.43 -51.67 67.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -42.21 -57.84 2.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.08 1.752 . . . . 0.0 109.917 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.18 72.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.113 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.5 mm -58.91 -58.65 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 121.433 -0.792 . . . . 0.0 109.502 174.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.8 t -49.89 -50.27 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.882 0.873 . . . . 0.0 110.24 -175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -43.3 -47.6 6.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.375 1.47 . . . . 0.0 112.441 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -59.74 -55.83 29.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.98 -48.91 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.985 0.914 . . . . 0.0 110.336 -175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -48.96 -68.82 0.15 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.318 0.647 . . . . 0.0 109.473 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -90.78 -22.41 21.05 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 123.701 0.625 . . . . 0.0 112.502 -152.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.35 156.61 10.95 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -150.39 -164.09 1.93 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.454 1.102 . . . . 0.0 111.997 -159.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.58 115.08 4.96 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.21 38.81 0.23 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.465 1.506 . . . . 0.0 113.498 -170.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.415 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.7 ttt -127.72 115.49 20.88 Favored Pre-proline 0 C--N 1.341 0.207 0 C-N-CA 124.016 0.926 . . . . 0.0 109.036 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 147.4 77.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.569 1.513 . . . . 0.0 111.322 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.5 154.13 39.43 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.642 1.177 . . . . 0.0 110.103 172.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -123.43 -1.52 8.59 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 111.766 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -51.49 141.4 15.95 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.95 -11.86 0.1 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.562 1.553 . . . . 0.0 115.293 -175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.04 -43.39 8.92 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.924 1.862 . . . . 0.0 109.987 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.6 mt -104.82 150.87 24.45 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -84.09 -174.3 5.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.61 0.764 . . . . 0.0 110.982 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.46 -64.21 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.91 1.284 . . . . 0.0 111.37 -171.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.56 -39.33 91.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 10' ' ' VAL . 51.6 tt0 -52.07 -62.71 1.46 Allowed 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.572 1.549 . . . . 0.0 110.262 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -50.33 -59.25 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.749 1.22 . . . . 0.0 110.089 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.79 -29.79 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.747 -0.595 . . . . 0.0 110.985 -174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.26 -45.45 8.83 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.34 -42.29 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 117.705 0.752 . . . . 0.0 109.402 176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -55.73 31.17 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.567 172.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.62 -40.19 71.81 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.944 0.498 . . . . 0.0 112.336 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.6 -54.54 30.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.827 0.851 . . . . 0.0 109.787 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 t -47.52 -45.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -56.85 -57.09 13.98 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 119.055 -0.498 . . . . 0.0 111.111 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -53.01 -58.22 7.73 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 122.755 1.264 . . . . 0.0 110.85 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -50.59 -42.89 56.31 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.297 2.639 . . . . 0.0 110.362 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.51 -34.91 30.95 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.06 1.344 . . . . 0.0 112.631 176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.32 -48.96 78.87 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.725 -1.234 . . . . 0.0 111.27 -173.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.3 8.59 78.17 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 123.763 0.664 . . . . 0.0 111.895 171.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.21 52.13 0.34 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 128.152 2.581 . . . . 0.0 111.913 -171.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpt -94.53 32.08 1.65 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.729 0.812 . . . . 0.0 110.067 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.4 m95 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.367 -1.301 . . . . 0.0 110.398 176.201 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.415 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.26 -162.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.572 0.749 . . . . 0.0 110.048 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.81 115.57 23.54 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.961 0.8 . . . . 0.0 110.272 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.5 mt -70.39 -28.09 64.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.522 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.83 -52.89 17.6 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 119.056 0.844 . . . . 0.0 110.73 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -51.36 -57.7 8.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.081 0.952 . . . . 0.0 109.026 171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 -43.62 80.75 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -57.78 -55.26 37.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 118.215 1.007 . . . . 0.0 110.748 173.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.38 -45.72 55.58 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.141 0.577 . . . . 0.0 111.159 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.8 t -59.62 -53.87 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -49.8 -58.57 5.1 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.807 1.243 . . . . 0.0 111.814 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -45.11 -42.88 9.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.044 2.138 . . . . 0.0 111.243 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.54 -48.01 6.1 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.96 -34.45 10.1 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -159.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.0 m -110.44 -44.26 3.74 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.113 0.965 . . . . 0.0 109.565 -160.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.82 -31.2 11.29 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.596 1.158 . . . . 0.0 112.408 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.95 -48.23 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.41 1.084 . . . . 0.0 111.813 170.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -104.11 -28.94 11.18 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.702 0.801 . . . . 0.0 110.921 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -118.28 29.93 7.51 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.12 122.73 0.23 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.034 1.334 . . . . 0.0 112.518 175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.66 -102.46 0.83 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -161.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.66 33.05 2.32 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 164.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.29 90.62 0.74 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 125.038 1.304 . . . . 0.0 112.148 -160.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -52.8 104.62 0.09 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.933 0.893 . . . . 0.0 111.775 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -90.03 4.96 48.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.248 0.619 . . . . 0.0 112.615 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -104.91 -61.44 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 123.619 0.768 . . . . 0.0 110.083 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.93 95.53 15.14 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.78 -49.07 4.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 125.288 3.992 . . . . 0.0 116.284 -162.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -88.6 -14.28 37.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.399 1.479 . . . . 0.0 112.781 -169.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.55 54.59 1.49 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.386 0.994 . . . . 0.0 109.422 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.1 p -77.48 176.3 9.02 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.101 1.36 . . . . 0.0 110.485 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.14 17.05 10.1 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.437 -0.789 . . . . 0.0 112.561 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -67.51 146.82 53.57 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.134 -0.979 . . . . 0.0 109.612 174.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -43.65 -58.54 2.62 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.099 0.56 . . . . 0.0 109.72 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.03 -33.49 62.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.582 0.753 . . . . 0.0 112.849 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.26 -47.53 42.33 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.15 -55.88 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.193 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.411 ' CG ' ' HB2' ' A' ' 45' ' ' PHE . 69.3 mt-10 -63.56 -33.1 74.84 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.472 0.578 . . . . 0.0 112.215 -168.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -69.1 -61.69 1.69 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.688 0.28 . . . . 0.0 110.627 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -87.04 -41.83 13.55 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -161.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 41' ' ' LEU . 9.4 tp -63.65 113.64 3.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.02 0.827 . . . . 0.0 112.632 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -40.88 -48.03 3.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.871 1.668 . . . . 0.0 111.287 165.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.31 -14.55 79.19 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 71.76 176.53 26.16 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 119.965 1.882 . . . . 0.0 112.537 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB2' ' CG ' ' A' ' 38' ' ' GLU . 34.5 t80 -72.89 71.84 1.07 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 122.013 -0.698 . . . . 0.0 111.463 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -132.14 148.5 52.48 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.052 0.941 . . . . 0.0 109.109 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.1 mm -64.59 -51.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -38.51 -58.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.651 1.98 . . . . 0.0 110.237 171.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.32 -51.83 61.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.869 0.867 . . . . 0.0 112.52 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.43 -56.04 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 121.636 -0.665 . . . . 0.0 109.349 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.92 -51.17 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 O-C-N 121.745 -0.597 . . . . 0.0 109.664 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -46.53 -48.22 19.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.563 1.545 . . . . 0.0 112.005 174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -57.4 -55.63 32.33 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.24 -48.69 86.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.837 0.855 . . . . 0.0 110.8 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -51.07 -67.35 0.26 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -91.88 -20.36 21.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.864 0.728 . . . . 0.0 112.373 -152.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.78 158.1 11.9 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.212 0.46 . . . . 0.0 111.966 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -150.2 -166.85 2.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.816 1.246 . . . . 0.0 111.405 -163.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -51.82 119.14 8.13 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.11 38.83 0.07 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.164 1.786 . . . . 0.0 113.934 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 11.0 ttt -129.13 114.86 18.67 Favored Pre-proline 0 C--N 1.34 0.182 0 C-N-CA 123.897 0.879 . . . . 0.0 109.421 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.29 147.88 91.0 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.83 1.687 . . . . 0.0 111.16 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.31 141.73 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.17 1.388 . . . . 0.0 108.281 173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -112.03 7.87 19.94 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.762 0.71 . . . . 0.0 111.477 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.4 120.73 3.4 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.48 1.112 . . . . 0.0 110.736 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.04 4.45 15.3 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.358 0.98 . . . . 0.0 114.768 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -93.9 -37.87 11.5 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.18 1.49 . . . . 0.0 108.997 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.4 151.48 22.22 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 167.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -69.28 169.1 12.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.636 0.731 . . . . 0.0 110.044 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -62.09 -47.63 83.79 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.989 0.916 . . . . 0.0 109.781 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -63.22 -49.23 75.01 Favored 'General case' 0 C--O 1.228 -0.045 0 CA-C-O 122.488 1.137 . . . . 0.0 109.195 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -50.38 -61.01 2.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.941 1.696 . . . . 0.0 111.148 176.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mm -44.47 -57.33 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.597 1.559 . . . . 0.0 109.874 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.52 -39.37 73.23 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 111.376 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.07 -46.94 40.52 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.66 -43.47 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.612 0.706 . . . . 0.0 110.529 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.55 -59.25 5.67 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.18 -0.325 . . . . 0.0 111.205 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.35 70.77 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -59.46 -59.56 5.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.096 0.958 . . . . 0.0 110.479 174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.2 t -50.48 -44.69 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -58.12 -51.51 69.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.464 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -61.03 -53.26 59.44 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.498 1.142 . . . . 0.0 110.742 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 7.5 tp-100 -49.67 -54.24 19.8 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.254 2.222 . . . . 0.0 109.878 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.72 -50.22 58.53 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.357 1.063 . . . . 0.0 112.131 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.59 -48.42 63.21 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 124.65 1.18 . . . . 0.0 109.984 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.97 -5.37 79.99 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.245 -1.308 . . . . 0.0 113.536 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.6 t30 25.06 68.74 0.04 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.155 1.382 . . . . 0.0 111.45 -151.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -79.8 -7.62 58.78 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.078 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.53 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.1 m95 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.777 -1.106 . . . . 0.0 110.525 171.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.421 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.405 ' N ' ' OD2' ' A' ' 82' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.31 -138.28 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.803 0.841 . . . . 0.0 109.338 -168.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -100.32 143.12 30.88 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 164.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.52 -29.63 16.87 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.954 1.302 . . . . 0.0 110.266 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.05 37.4 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.933 0.788 . . . . 0.0 111.061 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 tp -52.9 -58.12 7.98 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.197 0.999 . . . . 0.0 108.756 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.56 -44.61 68.05 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -57.75 -54.91 41.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 117.961 0.881 . . . . 0.0 110.728 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.69 -46.05 49.53 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.287 0.635 . . . . 0.0 111.166 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -60.35 -53.3 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -49.89 -58.87 4.52 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.996 1.318 . . . . 0.0 111.732 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -45.63 -40.65 9.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.928 2.091 . . . . 0.0 111.338 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.2 -49.03 5.44 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -100.04 -32.38 10.97 Favored 'General case' 0 CA--C 1.526 0.036 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -160.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.03 -46.1 3.13 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.105 0.962 . . . . 0.0 109.466 -159.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.17 -32.0 9.41 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.585 1.154 . . . . 0.0 112.125 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.24 -45.42 1.37 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.839 1.256 . . . . 0.0 112.377 170.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.6 m -106.55 -32.23 8.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.76 0.824 . . . . 0.0 110.957 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -113.28 30.68 7.01 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.113 0.965 . . . . 0.0 113.541 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -31.87 120.66 0.27 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.805 1.242 . . . . 0.0 112.326 175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.7 -99.75 0.63 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -162.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.46 27.13 2.88 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 164.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 88.37 1.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 125.099 1.333 . . . . 0.0 111.663 -161.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -48.66 108.88 0.2 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.653 0.781 . . . . 0.0 111.324 174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -79.44 -23.02 43.41 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.371 0.668 . . . . 0.0 111.607 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.97 -51.7 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -172.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 mt -117.07 92.13 38.44 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -40.02 -46.6 3.95 Favored 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.573 4.182 . . . . 0.0 116.425 -167.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -85.84 -15.76 40.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.568 1.547 . . . . 0.0 112.53 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -85.32 52.26 2.4 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 -175.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.1 p -76.69 164.88 25.46 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 127.067 2.147 . . . . 0.0 110.996 -172.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.1 mt -76.08 34.25 0.13 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.15 -0.969 . . . . 0.0 112.801 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -81.56 147.94 29.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.151 -0.968 . . . . 0.0 109.049 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -47.66 -60.0 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 172.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.4 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.886 0.874 . . . . 0.0 112.026 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.51 -41.43 46.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.411 0.684 . . . . 0.0 109.166 -170.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mt -50.88 -54.27 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -61.76 -33.91 74.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -67.63 -60.8 2.26 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.874 0.761 . . . . 0.0 111.812 168.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -89.54 -39.07 13.54 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -159.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.32 106.39 1.1 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.74 0.7 . . . . 0.0 111.21 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -30.15 -61.8 0.16 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.625 1.57 . . . . 0.0 112.717 166.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.24 -20.48 75.11 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.502 -1.166 . . . . 0.0 115.533 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.98 -175.46 43.3 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 120.398 2.099 . . . . 0.0 112.861 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -74.98 73.38 2.17 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.909 -0.76 . . . . 0.0 111.975 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -146.87 154.26 41.11 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.792 -0.568 . . . . 0.0 110.775 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.1 mm -54.08 -45.26 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.929 0.891 . . . . 0.0 108.748 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.5 mp0 -50.7 -60.41 3.07 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.989 0.916 . . . . 0.0 109.585 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.97 -50.21 47.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 125.195 1.398 . . . . 0.0 112.39 175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -57.83 -56.83 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 O-C-N 121.625 -0.672 . . . . 0.0 109.668 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.05 -49.63 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.6 -46.2 57.84 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.961 1.304 . . . . 0.0 111.282 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -59.48 -51.24 70.71 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.519 -0.738 . . . . 0.0 109.511 176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -58.17 -48.61 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -53.92 -71.64 0.07 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 123.745 0.818 . . . . 0.0 109.235 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -108.1 62.06 0.61 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.104 1.362 . . . . 0.0 110.9 -170.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -27.15 135.25 0.03 OUTLIER Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.084 2.278 . . . . 0.0 113.694 165.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -106.04 -159.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.445 0.698 . . . . 0.0 109.268 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 21.32 -87.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 127.843 2.639 . . . . 0.0 116.002 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.01 23.52 4.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.527 1.131 . . . . 0.0 111.211 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.431 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 7.9 ttt -104.78 125.44 33.86 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 124.137 0.975 . . . . 0.0 108.834 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 130.81 29.27 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 121.212 1.275 . . . . 0.0 108.892 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.04 146.32 49.41 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.579 1.151 . . . . 0.0 108.487 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -112.46 9.37 19.63 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.118 0.872 . . . . 0.0 111.761 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -47.12 119.52 2.62 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.305 1.042 . . . . 0.0 110.944 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.42 14.92 43.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.727 1.156 . . . . 0.0 114.658 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -101.35 -40.86 6.91 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.855 1.327 . . . . 0.0 109.346 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.52 152.63 19.35 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -77.12 173.78 11.44 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.979 0.895 . . . . 0.0 110.564 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.16 -52.95 62.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.199 0.999 . . . . 0.0 110.309 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.36 -49.6 76.28 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 122.334 1.064 . . . . 0.0 109.502 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -49.61 -60.57 2.75 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.954 1.702 . . . . 0.0 110.98 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -46.27 -57.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.602 1.561 . . . . 0.0 109.731 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -39.31 73.31 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.435 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.51 -46.89 30.34 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -172.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.93 -42.77 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 117.076 0.438 . . . . 0.0 110.477 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.01 -58.31 8.75 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.138 -0.351 . . . . 0.0 111.053 172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.92 -37.01 68.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.054 0.542 . . . . 0.0 112.304 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -59.33 -62.12 2.12 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.726 0.81 . . . . 0.0 110.198 176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.5 t -48.92 -45.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 123.419 0.688 . . . . 0.0 109.602 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -57.34 -52.77 64.02 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.536 -0.269 . . . . 0.0 111.629 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 3.3 t70 -62.66 -50.54 70.78 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.275 1.036 . . . . 0.0 110.803 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -52.66 -46.94 67.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.881 2.873 . . . . 0.0 110.084 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.99 -53.31 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 111.608 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.54 63.02 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.095 1.358 . . . . 0.0 110.64 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.96 -2.67 78.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.599 -1.111 . . . . 0.0 113.331 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.36 60.14 2.17 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.821 1.248 . . . . 0.0 110.54 -162.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -91.67 2.01 56.76 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.243 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 22.1 m95 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.506 -1.235 . . . . 0.0 108.584 164.067 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.431 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.07 47.5 9.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.366 1.066 . . . . 0.0 111.713 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.76 151.79 41.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.919 0.866 . . . . 0.0 111.298 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.0 mt -77.5 -36.29 52.77 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.723 1.609 . . . . 0.0 110.312 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -44.32 63.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 119.15 0.886 . . . . 0.0 110.11 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.22 -57.79 7.02 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.619 1.167 . . . . 0.0 108.54 166.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 -45.56 31.25 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -59.28 -56.37 22.93 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 118.006 0.903 . . . . 0.0 110.394 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.29 -45.35 44.97 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.287 0.635 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.47 -56.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.63 -60.47 2.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.062 1.345 . . . . 0.0 111.278 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -45.15 -40.7 7.31 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.199 2.2 . . . . 0.0 111.551 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.15 -46.11 6.01 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -103.96 -38.0 7.16 Favored 'General case' 0 C--N 1.335 -0.059 0 C-N-CA 123.633 0.773 . . . . 0.0 112.273 -159.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.4 m -103.1 -43.67 5.42 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.231 1.012 . . . . 0.0 108.993 -163.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -34.69 2.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.394 1.478 . . . . 0.0 112.083 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.89 -45.02 1.75 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.939 1.296 . . . . 0.0 112.407 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.3 m -109.67 -30.18 8.01 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.782 0.833 . . . . 0.0 111.208 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -114.0 19.22 16.69 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 3.98 -82.25 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.254 2.222 . . . . 0.0 116.09 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.2 55.92 0.48 Allowed Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.118 0.866 . . . . 0.0 110.965 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.99 15.84 65.55 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.92 85.37 0.51 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 125.882 1.706 . . . . 0.0 111.178 -161.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -51.03 112.11 0.67 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.964 0.906 . . . . 0.0 111.432 177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.96 -22.24 36.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.266 0.626 . . . . 0.0 111.626 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.56 -53.17 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 118.636 0.653 . . . . 0.0 109.443 -173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.18 94.56 45.27 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -40.55 -48.28 4.35 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.53 4.153 . . . . 0.0 115.847 -166.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -85.51 -13.68 48.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.917 1.687 . . . . 0.0 112.485 -172.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -84.71 52.34 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.152 -0.967 . . . . 0.0 109.286 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -74.83 163.59 27.5 Favored 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 127.091 2.157 . . . . 0.0 111.134 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.3 mt -77.79 35.58 0.2 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.128 -0.982 . . . . 0.0 112.579 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -86.4 151.16 23.77 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 109.643 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -51.51 -58.64 5.74 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.21 63.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.36 0.664 . . . . 0.0 111.787 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.75 -41.51 68.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -172.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 mt -53.66 -59.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.755 167.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -61.88 -32.25 72.6 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.866 -0.521 . . . . 0.0 112.332 -169.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -71.71 -64.43 0.93 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.207 0.458 . . . . 0.0 111.878 168.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -79.68 -44.88 20.04 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' LEU . 7.1 tp -63.27 97.75 0.13 Allowed 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 118.437 0.562 . . . . 0.0 111.945 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -7.24 -70.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.84 2.056 . . . . 0.0 113.751 147.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 1.57 71.02 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 115.412 0.925 . . . . 0.0 115.412 -173.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.73 177.81 39.5 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.818 1.809 . . . . 0.0 112.416 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -71.77 72.26 0.78 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.023 0.529 . . . . 0.0 110.576 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -135.04 143.01 46.51 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.013 0.925 . . . . 0.0 108.975 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.55 -47.96 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -40.14 -60.09 1.12 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.269 1.827 . . . . 0.0 110.648 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.04 -50.23 67.17 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.84 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.27 -61.22 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.31 -51.42 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 124.455 1.102 . . . . 0.0 109.811 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -48.32 -47.04 37.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.433 1.093 . . . . 0.0 111.726 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.56 -52.54 64.01 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.04 -50.03 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.013 0.525 . . . . 0.0 110.886 -178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -50.66 -68.27 0.18 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -89.29 -25.32 21.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.932 -152.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.3 136.18 0.15 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.48 136.49 18.46 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -160.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.77 -114.4 6.28 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.62 24.62 12.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.827 0.851 . . . . 0.0 111.62 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -108.25 129.1 24.5 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.698 0.799 . . . . 0.0 110.083 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.33 156.3 64.85 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.447 2.098 . . . . 0.0 111.233 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.96 143.51 27.07 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.465 1.506 . . . . 0.0 109.521 -178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -114.43 5.61 15.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.36 0.664 . . . . 0.0 111.678 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -44.04 119.41 1.75 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 124.612 1.165 . . . . 0.0 110.994 173.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.3 -2.43 5.5 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.967 -0.907 . . . . 0.0 115.102 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -85.69 -38.44 18.32 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 119.37 1.585 . . . . 0.0 109.085 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.9 mt -104.15 151.31 23.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.72 168.69 12.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.706 0.765 . . . . 0.0 109.968 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -61.46 -47.02 87.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.009 0.923 . . . . 0.0 109.792 177.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.18 -45.18 81.76 Favored 'General case' 0 C--O 1.227 -0.094 0 CA-C-O 122.29 1.043 . . . . 0.0 109.549 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -53.11 -60.21 3.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.058 1.743 . . . . 0.0 110.677 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mm -43.67 -57.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.503 1.521 . . . . 0.0 109.985 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.01 72.43 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.773 -0.58 . . . . 0.0 111.614 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.27 -46.39 50.06 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -43.37 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 122.449 -0.442 . . . . 0.0 110.076 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.64 -55.62 31.74 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.366 172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.92 -47.6 64.58 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.996 0.518 . . . . 0.0 111.841 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.51 -54.22 49.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.147 0.979 . . . . 0.0 111.08 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t -53.22 -46.7 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -57.52 -48.81 78.26 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.845 0.458 . . . . 0.0 110.904 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -59.28 -47.68 84.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.2 1.0 . . . . 0.0 111.445 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -57.62 -51.93 67.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.87 0.868 . . . . 0.0 110.092 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.24 -60.4 3.67 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.152 0.581 . . . . 0.0 110.513 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.2 63.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.315 1.046 . . . . 0.0 111.057 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.65 77.52 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.079 -0.845 . . . . 0.0 113.129 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 48.88 66.54 1.06 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.986 0.893 . . . . 0.0 110.526 -159.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -105.62 16.31 25.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.513 0.725 . . . . 0.0 110.469 167.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.7 m95 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 153.725 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.424 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.87 60.06 0.51 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.604 1.162 . . . . 0.0 111.421 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -77.68 151.8 34.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.619 1.168 . . . . 0.0 110.767 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.58 -37.67 62.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.525 1.53 . . . . 0.0 109.984 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.1 -47.08 60.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.842 0.746 . . . . 0.0 110.295 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.57 -56.06 13.42 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.074 0.95 . . . . 0.0 109.207 168.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.84 -46.08 40.15 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -58.92 -54.55 45.9 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 117.966 0.883 . . . . 0.0 110.713 175.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.5 -45.96 47.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.095 0.558 . . . . 0.0 111.127 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.8 -54.93 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -47.44 -59.56 3.13 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.219 1.407 . . . . 0.0 111.711 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -46.52 -41.33 14.02 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.16 2.184 . . . . 0.0 111.381 178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.62 -46.85 5.88 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -99.96 -37.39 9.03 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.527 0.731 . . . . 0.0 112.323 -160.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.5 m -105.57 -45.02 4.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.01 0.924 . . . . 0.0 109.248 -161.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.13 -33.27 4.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.692 1.197 . . . . 0.0 112.458 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.19 -46.66 1.51 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.905 1.282 . . . . 0.0 112.406 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.7 m -105.87 -30.18 9.53 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.71 0.804 . . . . 0.0 110.569 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -114.37 30.66 7.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.83 125.9 1.92 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.428 1.013 . . . . 0.0 111.492 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.34 31.62 66.54 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.741 0.686 . . . . 0.0 113.179 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.33 22.19 67.15 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 117.853 0.827 . . . . 0.0 112.119 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.16 -159.5 10.5 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -150.13 117.87 6.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 -11.01 59.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.515 0.598 . . . . 0.0 111.437 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.32 -58.06 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.983 0.81 . . . . 0.0 110.292 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mt -114.22 93.11 29.56 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -46.46 -46.12 17.89 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 124.174 3.249 . . . . 0.0 115.473 -158.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -84.14 -11.97 55.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.791 2.036 . . . . 0.0 112.719 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -82.78 56.91 3.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.316 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.4 p -83.77 157.41 22.11 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.839 1.656 . . . . 0.0 111.483 -170.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.44 37.16 0.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.209 -0.932 . . . . 0.0 113.297 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.91 147.0 44.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.633 1.106 . . . . 0.0 110.998 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.0 tttm -33.45 -66.51 0.15 Allowed 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 125.971 1.708 . . . . 0.0 112.382 -168.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.88 -51.06 13.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.856 0.863 . . . . 0.0 112.543 -177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.69 -41.13 75.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -53.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.981 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -65.04 -33.64 76.52 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.94 -0.475 . . . . 0.0 112.149 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -70.73 -63.09 1.16 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.387 0.539 . . . . 0.0 111.453 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -75.62 -46.07 33.79 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -165.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 41' ' ' LEU . 10.4 tp -62.85 107.54 1.0 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 118.783 0.72 . . . . 0.0 112.645 -172.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -29.64 -61.59 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.396 1.878 . . . . 0.0 112.551 162.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.88 -9.72 35.19 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.41 175.02 39.52 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.629 1.715 . . . . 0.0 110.463 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -72.82 121.01 19.25 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.739 -0.859 . . . . 0.0 109.296 173.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 p30 175.46 153.06 0.14 Allowed 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.995 1.718 . . . . 0.0 107.598 175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.4 mm -56.28 -45.14 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.7 mp0 -49.55 -61.35 2.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.731 1.212 . . . . 0.0 110.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -49.4 -51.26 36.32 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.78 1.232 . . . . 0.0 112.003 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -55.9 -58.32 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.7 t -51.58 -51.05 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -53.69 -38.59 64.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.573 1.149 . . . . 0.0 111.794 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -66.43 -52.37 47.22 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.898 0.772 . . . . 0.0 109.206 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.25 -49.9 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -51.61 -69.99 0.1 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -108.74 60.47 0.6 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.847 2.059 . . . . 0.0 108.815 -159.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -37.85 142.21 0.31 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.908 1.718 . . . . 0.0 113.733 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -101.59 166.17 10.85 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.14 0.976 . . . . 0.0 108.668 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 39.2 -100.37 0.01 OUTLIER Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.299 1.428 . . . . 0.0 114.729 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.01 16.73 21.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.436 1.094 . . . . 0.0 112.51 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.1 ttt -92.59 128.04 45.9 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.703 1.201 . . . . 0.0 108.604 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -58.85 -15.06 24.97 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.684 2.923 . . . . 0.0 116.613 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.74 159.27 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.419 1.088 . . . . 0.0 109.869 -168.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -135.04 19.74 3.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.932 -1.105 . . . . 0.0 111.546 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -45.45 113.96 0.67 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.148 1.779 . . . . 0.0 111.765 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.17 17.49 31.05 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.591 1.091 . . . . 0.0 113.746 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -92.1 -44.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.358 1.079 . . . . 0.0 108.835 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.83 157.25 16.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.414 1.085 . . . . 0.0 108.417 176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -69.44 166.69 18.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.595 0.712 . . . . 0.0 109.902 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -61.53 -45.94 92.06 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.603 0.761 . . . . 0.0 109.585 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.79 -46.9 80.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 122.255 1.026 . . . . 0.0 109.441 -177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -53.24 -61.2 2.46 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 126.477 1.911 . . . . 0.0 110.848 175.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.0 mm -43.75 -55.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 125.603 1.561 . . . . 0.0 109.802 172.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.23 77.23 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.908 -0.495 . . . . 0.0 111.669 -178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.01 -48.12 34.51 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -42.89 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 122.41 -0.465 . . . . 0.0 109.779 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -55.97 26.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.865 0.302 . . . . 0.0 111.489 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.65 -47.25 58.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 0.0 112.228 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -60.03 -53.45 57.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 121.765 -0.585 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.2 t -54.71 -45.42 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -57.1 -50.79 71.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.828 0.451 . . . . 0.0 110.748 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -55.37 -55.74 28.08 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.238 0.542 . . . . 0.0 110.628 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 89' ' ' TRP . 13.9 mm100 -48.78 -53.86 17.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.726 0.811 . . . . 0.0 110.268 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.41 -50.46 73.86 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.801 0.84 . . . . 0.0 111.327 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.56 -53.8 53.33 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.82 1.248 . . . . 0.0 110.855 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.94 -16.09 76.42 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 41.23 32.14 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 126.387 1.875 . . . . 0.0 109.49 -168.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.49 33.56 2.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.062 0.945 . . . . 0.0 111.139 -168.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' CE2' ' HB3' ' A' ' 83' ' ' GLN . 91.2 m95 . . . . . 0 C--O 1.252 1.208 0 CA-C-O 116.997 -1.477 . . . . 0.0 109.246 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 1.2 pm0 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 120.92 0.39 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 40.48 26.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.54 1.136 . . . . 0.0 111.523 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -72.3 149.27 44.61 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 110.782 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.04 -36.48 59.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.481 1.513 . . . . 0.0 110.213 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.3 -46.24 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.032 0.833 . . . . 0.0 110.106 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.0 tp -50.33 -57.74 7.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.866 1.267 . . . . 0.0 108.654 167.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.97 -45.26 32.52 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 44.9 tttp -61.76 -55.61 28.32 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.756 -0.849 . . . . 0.0 110.847 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.35 -46.35 25.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.089 0.556 . . . . 0.0 111.044 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.45 -58.06 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 173.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -46.63 -59.69 2.85 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.055 1.342 . . . . 0.0 111.489 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.504 ' CG ' ' HZ2' ' A' ' 8' ' ' LYS . 21.3 m-20 -51.95 -35.22 45.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.564 1.946 . . . . 0.0 111.099 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.1 -43.91 6.49 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 118.406 0.548 . . . . 0.0 112.039 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -105.02 -36.63 7.24 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.843 0.857 . . . . 0.0 112.414 -159.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.16 -44.72 4.29 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.448 1.099 . . . . 0.0 109.133 -162.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.28 -31.91 6.59 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.715 1.206 . . . . 0.0 112.155 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.55 -46.19 1.16 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.902 1.281 . . . . 0.0 112.34 170.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.9 m -106.61 -30.47 8.99 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.656 0.783 . . . . 0.0 110.964 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -114.72 33.53 5.31 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.567 1.147 . . . . 0.0 113.451 -170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.46 120.46 1.94 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 111.185 174.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.53 35.07 88.23 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 121.894 -0.504 . . . . 0.0 112.864 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.87 9.04 62.03 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 121.952 -0.734 . . . . 0.0 112.336 -172.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.17 90.08 1.31 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.249 0.928 . . . . 0.0 111.094 -162.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -48.47 114.48 0.97 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.431 0.692 . . . . 0.0 111.337 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -86.55 -11.02 52.77 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.427 0.691 . . . . 0.0 111.795 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.48 -63.12 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.552 0.741 . . . . 0.0 110.44 -169.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 mt -105.26 95.48 9.72 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.05 -37.87 61.21 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.547 2.831 . . . . 0.0 114.123 -151.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -77.27 -19.82 55.98 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.056 1.342 . . . . 0.0 111.832 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -84.74 53.41 2.69 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.715 0.769 . . . . 0.0 109.613 -171.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.9 p -76.57 163.53 26.81 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 126.203 1.801 . . . . 0.0 111.375 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.08 44.16 0.55 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.302 -0.874 . . . . 0.0 111.791 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -92.7 149.87 21.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.427 1.091 . . . . 0.0 109.079 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -50.16 -59.29 4.07 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.0 -35.24 64.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.307 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.93 -43.71 43.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -54.79 -58.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.097 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -61.08 -31.57 71.24 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.571 -0.706 . . . . 0.0 111.934 -168.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -69.81 -64.94 0.79 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.57 0.348 . . . . 0.0 111.286 168.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.42 -40.99 18.63 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -161.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.44 108.64 0.84 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.477 0.711 . . . . 0.0 110.887 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -33.13 -64.28 0.2 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.828 1.651 . . . . 0.0 112.509 167.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.23 -1.34 63.81 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.812 -0.993 . . . . 0.0 115.069 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.66 -173.84 54.92 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 120.18 1.99 . . . . 0.0 112.05 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -73.53 70.94 1.32 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.825 0.45 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -134.63 144.99 48.19 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.029 0.932 . . . . 0.0 108.905 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.95 -49.1 84.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -42.61 -57.95 2.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.829 1.652 . . . . 0.0 110.237 172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.31 71.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.911 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -56.63 -58.44 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 121.736 -0.603 . . . . 0.0 109.743 175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.33 -49.8 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 123.856 0.862 . . . . 0.0 109.791 -177.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -49.69 -46.59 50.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.356 1.062 . . . . 0.0 111.453 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -57.08 -56.83 16.72 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.01 -44.62 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.562 0.745 . . . . 0.0 110.41 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -54.86 -74.32 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.042 0.937 . . . . 0.0 109.725 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -95.76 -7.73 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -164.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.3 160.55 27.58 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.471 1.032 . . . . 0.0 112.742 169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -146.72 -164.29 1.95 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.806 1.243 . . . . 0.0 112.264 -162.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.94 120.08 15.88 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 36.09 38.7 0.07 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.593 1.557 . . . . 0.0 113.498 -169.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 11.5 ttt -130.07 112.79 17.2 Favored Pre-proline 0 C--N 1.34 0.169 0 C-N-CA 123.871 0.868 . . . . 0.0 109.393 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.92 149.08 86.62 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 121.462 1.441 . . . . 0.0 111.836 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.4 153.36 41.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.716 1.207 . . . . 0.0 110.018 171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -120.11 0.12 10.64 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.402 0.681 . . . . 0.0 111.591 174.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -45.07 135.2 5.59 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.712 0.805 . . . . 0.0 109.806 165.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.93 -10.36 0.13 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.378 1.466 . . . . 0.0 115.312 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -92.48 -41.5 10.24 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.712 1.756 . . . . 0.0 109.496 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.1 mt -104.39 153.67 20.8 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.67 0.788 . . . . 0.0 109.234 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.54 169.4 14.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.613 0.721 . . . . 0.0 110.005 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.38 -47.5 81.81 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.121 0.968 . . . . 0.0 109.77 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 30.1 t0 -62.32 -47.75 82.86 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 122.658 1.218 . . . . 0.0 108.638 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -54.4 -61.15 2.49 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.538 1.935 . . . . 0.0 111.125 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.1 mm -43.29 -57.05 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.386 1.474 . . . . 0.0 110.001 171.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.64 73.25 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.927 -0.483 . . . . 0.0 111.375 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.56 -47.58 48.97 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.0 -43.31 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 122.316 -0.52 . . . . 0.0 110.175 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.1 -55.35 34.09 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.268 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.26 -45.2 65.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.937 0.495 . . . . 0.0 111.888 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -60.83 -51.82 67.71 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.504 0.721 . . . . 0.0 111.222 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 t -54.12 -45.76 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.87 -50.62 71.94 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.683 0.393 . . . . 0.0 110.993 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.77 -53.72 53.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.39 1.076 . . . . 0.0 110.946 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -50.89 -53.3 33.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.87 0.868 . . . . 0.0 110.596 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.31 56.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.541 0.736 . . . . 0.0 111.189 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.62 -53.45 54.54 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.891 0.876 . . . . 0.0 110.809 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.35 75.51 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.872 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.32 54.37 6.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.526 1.131 . . . . 0.0 108.474 -171.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -118.23 26.48 9.6 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 110.778 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 77.4 m95 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.213 -1.375 . . . . 0.0 108.863 156.785 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.42 44.88 29.38 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.935 1.243 . . . . 0.0 110.826 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -71.98 152.13 42.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.79 -37.3 59.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.276 1.43 . . . . 0.0 110.025 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.57 -45.3 65.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.797 0.726 . . . . 0.0 110.072 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.02 -58.23 5.92 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.112 1.365 . . . . 0.0 108.776 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -45.71 39.23 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -59.66 -56.79 17.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 121.589 -0.948 . . . . 0.0 110.372 175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.2 -46.32 23.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.242 0.617 . . . . 0.0 111.409 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.3 t -58.39 -56.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 173.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -47.83 -60.08 2.85 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.864 1.266 . . . . 0.0 111.568 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.08 -37.57 15.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.594 1.957 . . . . 0.0 111.653 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.53 -46.72 5.96 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.485 0.584 . . . . 0.0 111.739 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -103.16 -34.16 8.94 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.615 0.766 . . . . 0.0 112.643 -158.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.1 m -110.66 -42.84 3.95 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.354 1.062 . . . . 0.0 109.084 -160.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.4 -35.65 3.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.136 1.375 . . . . 0.0 111.663 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.65 -47.21 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 113.209 173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.52 -34.29 7.08 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.249 0.62 . . . . 0.0 111.359 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -96.58 -30.9 13.02 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.379 0.671 . . . . 0.0 112.576 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 44.61 -118.69 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 111.083 -173.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.86 3.44 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.887 0.767 . . . . 0.0 111.669 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.96 26.92 58.9 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 123.896 0.76 . . . . 0.0 113.872 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.8 -156.66 29.38 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 125.161 1.362 . . . . 0.0 110.342 174.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -151.36 124.54 8.76 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 164.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -81.3 -20.7 40.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.438 0.563 . . . . 0.0 112.187 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -103.43 -57.33 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.624 0.769 . . . . 0.0 111.491 -165.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.9 mt -109.32 91.76 10.35 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.81 -43.05 24.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.525 3.484 . . . . 0.0 115.306 -161.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -84.19 -20.32 32.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.538 1.935 . . . . 0.0 112.492 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -77.68 58.13 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.997 0.817 . . . . 0.0 109.294 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.8 p -82.35 176.06 9.75 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.182 0.993 . . . . 0.0 110.521 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.9 mt -96.69 16.14 19.85 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.639 -0.663 . . . . 0.0 112.156 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -69.21 145.72 52.97 Favored 'General case' 0 N--CA 1.461 0.086 0 O-C-N 120.958 -1.089 . . . . 0.0 108.804 173.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -40.22 -61.69 0.85 Allowed 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 123.651 0.78 . . . . 0.0 110.156 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.97 -39.84 63.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.92 0.888 . . . . 0.0 112.47 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.43 -45.5 72.4 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.66 -54.16 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 123.121 0.569 . . . . 0.0 110.153 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -61.01 -29.35 69.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.682 -1.261 . . . . 0.0 112.356 -171.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.48 -64.58 0.96 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.184 0.594 . . . . 0.0 111.481 168.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -87.99 -31.61 19.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -160.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.5 105.27 0.28 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.813 0.845 . . . . 0.0 111.499 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -9.69 -70.59 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.386 2.675 . . . . 0.0 113.464 157.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.14 14.78 58.29 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.705 1.042 . . . . 0.0 115.705 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.18 178.81 52.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 120.099 1.95 . . . . 0.0 112.142 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.89 71.32 1.52 Allowed 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.437 -0.449 . . . . 0.0 110.762 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -131.38 144.3 51.11 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -63.06 -50.09 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -40.62 -59.91 1.26 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.477 1.911 . . . . 0.0 110.019 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.18 71.62 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.833 0.853 . . . . 0.0 112.139 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -55.45 -55.46 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.512 -0.743 . . . . 0.0 109.813 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.03 -52.63 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 O-C-N 121.817 -0.552 . . . . 0.0 109.535 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -48.65 -49.0 39.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.231 1.412 . . . . 0.0 111.465 174.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -54.49 -55.27 30.71 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.74 -43.86 88.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.181 0.992 . . . . 0.0 111.313 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.72 -70.72 0.12 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.428 0.691 . . . . 0.0 109.565 -175.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -91.19 -17.54 25.9 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -167.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.32 143.31 0.81 Allowed Glycine 0 CA--C 1.534 1.257 0 CA-C-N 119.639 1.109 . . . . 0.0 113.159 172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -125.01 -151.4 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.848 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -48.94 118.47 5.06 Favored Glycine 0 C--O 1.221 -0.694 0 C-N-CA 125.103 1.335 . . . . 0.0 111.139 -175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 38.82 38.88 0.3 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.755 2.022 . . . . 0.0 113.968 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.0 ttt -124.58 123.89 25.71 Favored Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 90' ' ' HEM . 60.8 Cg_endo -66.29 139.04 53.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.445 1.43 . . . . 0.0 109.83 177.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.98 142.66 49.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.269 1.028 . . . . 0.0 108.656 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -109.64 4.39 22.0 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.633 0.651 . . . . 0.0 111.484 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -43.49 120.34 1.91 Allowed 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 124.482 1.113 . . . . 0.0 110.986 173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.02 -5.99 3.3 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 118.968 -0.906 . . . . 0.0 115.291 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -85.7 -38.9 17.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.461 1.631 . . . . 0.0 109.304 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.7 mt -102.93 151.62 22.25 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.9 168.44 11.69 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.665 0.745 . . . . 0.0 109.881 171.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -62.21 -46.26 89.68 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -67.2 -44.31 79.91 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.076 0.941 . . . . 0.0 109.504 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -53.97 -60.05 3.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.923 1.689 . . . . 0.0 110.606 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -43.66 -57.41 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.426 1.49 . . . . 0.0 109.849 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.09 69.55 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.807 -0.558 . . . . 0.0 111.554 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.88 -47.62 46.19 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -43.85 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 117.233 0.517 . . . . 0.0 109.903 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.15 -56.15 25.77 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.957 0.344 . . . . 0.0 111.574 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.09 -47.52 65.2 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.177 0.591 . . . . 0.0 111.57 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -57.57 -56.69 18.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.406 1.082 . . . . 0.0 111.013 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.2 t -50.37 -44.77 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -58.43 -52.43 65.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.605 0.362 . . . . 0.0 111.073 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.97 -55.36 35.92 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.159 0.981 . . . . 0.0 111.268 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 8.7 tp-100 -51.98 -50.77 60.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.143 2.577 . . . . 0.0 109.274 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.47 -51.46 51.07 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.507 1.123 . . . . 0.0 111.996 177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -49.0 64.29 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.407 1.083 . . . . 0.0 110.328 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.38 -13.56 73.92 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.412 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 29.46 71.92 0.06 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.167 0.987 . . . . 0.0 110.78 -147.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -78.17 -6.97 56.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.131 163.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.418 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 20.4 m95 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.599 -1.191 . . . . 0.0 110.372 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 62' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.404 ' N ' ' OD2' ' A' ' 71' ' ' ASP . 13.9 mp0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.38 41.27 31.24 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.046 0.938 . . . . 0.0 111.517 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -71.63 148.62 46.37 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.816 0.817 . . . . 0.0 110.845 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.21 -36.46 61.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.284 1.433 . . . . 0.0 110.231 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.57 -45.5 58.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.926 0.784 . . . . 0.0 110.156 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.9 tp -50.56 -56.37 12.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.523 1.129 . . . . 0.0 108.595 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.13 -47.57 33.1 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.2 tttm -58.53 -55.41 35.45 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 121.724 -0.869 . . . . 0.0 110.377 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.09 -45.64 52.79 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.358 0.663 . . . . 0.0 111.237 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.73 -55.16 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -49.22 -58.75 4.49 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.762 1.225 . . . . 0.0 111.523 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -45.15 -40.24 6.86 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 127.275 2.23 . . . . 0.0 111.596 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.64 -46.41 5.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -102.81 -35.62 8.56 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.507 0.723 . . . . 0.0 112.573 -158.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.1 m -106.85 -42.77 4.85 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.283 1.033 . . . . 0.0 109.046 -163.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.53 -34.09 4.59 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.747 1.219 . . . . 0.0 111.439 173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.3 -45.03 1.35 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.964 1.306 . . . . 0.0 113.24 172.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -110.67 -33.15 6.65 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.23 0.612 . . . . 0.0 111.981 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -99.45 -20.91 16.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.127 0.971 . . . . 0.0 112.804 -171.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 30.36 51.63 0.11 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.341 1.856 . . . . 0.0 114.401 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.44 -138.22 14.67 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.096 -2.802 . . . . 0.0 106.096 -161.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -98.54 10.89 63.07 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 118.752 1.276 . . . . 0.0 112.357 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.5 80.4 1.39 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 127.26 2.362 . . . . 0.0 113.519 -165.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -43.36 105.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.875 0.87 . . . . 0.0 110.936 162.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -76.11 -36.52 58.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.298 0.499 . . . . 0.0 110.701 171.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.41 -52.02 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 122.939 0.496 . . . . 0.0 111.005 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.0 mt -120.49 90.08 45.09 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -43.54 -42.26 11.03 Favored 'Trans proline' 0 C--N 1.348 0.535 1 C-N-CA 125.44 4.094 . . . . 0.0 116.438 -164.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -86.17 -21.97 27.25 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.55 1.54 . . . . 0.0 112.294 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.75 44.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.283 -0.886 . . . . 0.0 110.39 -171.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.1 p -67.28 167.95 11.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 126.405 1.882 . . . . 0.0 112.026 -170.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.72 33.89 0.12 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.938 -1.101 . . . . 0.0 112.475 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -82.29 150.34 27.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -50.74 -58.8 5.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 172.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.33 -32.04 55.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.757 0.823 . . . . 0.0 112.785 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.66 21.51 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mt -53.1 -55.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 168.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -61.37 -32.06 71.96 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.744 -0.597 . . . . 0.0 112.307 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.48 -64.2 1.0 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.929 0.491 . . . . 0.0 111.019 170.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -81.63 -41.02 22.06 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -163.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.16 110.91 1.33 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 118.989 0.813 . . . . 0.0 111.198 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' OD1' ' NZ ' ' A' ' 58' ' ' LYS . 16.5 p-10 -63.32 69.58 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.397 2.279 . . . . 0.0 109.456 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.54 -29.81 0.3 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.568 1.08 . . . . 0.0 113.091 -166.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.68 -177.41 54.38 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 118.972 1.386 . . . . 0.0 111.861 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -73.32 70.27 1.18 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -132.66 148.05 52.34 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.251 1.02 . . . . 0.0 108.882 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.1 mm -64.76 -50.26 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -41.12 -58.62 1.72 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.367 1.867 . . . . 0.0 110.199 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.62 64.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.089 0.955 . . . . 0.0 112.026 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -57.56 -55.93 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 O-C-N 121.597 -0.689 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.8 t -51.19 -51.33 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 O-C-N 121.63 -0.669 . . . . 0.0 109.587 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -46.85 -50.3 18.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.494 1.517 . . . . 0.0 111.659 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -55.29 -55.09 35.4 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.92 -43.4 92.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.71 0.804 . . . . 0.0 110.973 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -56.34 -74.22 0.05 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.734 0.814 . . . . 0.0 109.437 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.56 -14.38 32.66 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -165.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.23 162.88 7.48 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.5 1.045 . . . . 0.0 112.377 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OD1' ' A' ' 42' ' ' ASP . 1.5 mptm? -141.42 -177.39 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.417 1.087 . . . . 0.0 110.308 -166.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -8.57 -70.99 0.01 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 128.516 2.96 . . . . 0.0 116.172 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.44 33.84 4.02 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.906 1.283 . . . . 0.0 110.498 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.428 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 10.4 ttt -125.02 116.43 25.99 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 124.651 1.181 . . . . 0.0 109.341 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.2 146.55 81.75 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.942 1.761 . . . . 0.0 111.02 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.69 153.34 43.93 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.072 1.349 . . . . 0.0 110.261 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -123.25 6.5 9.1 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.418 0.687 . . . . 0.0 112.495 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -44.46 119.71 1.96 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.887 1.675 . . . . 0.0 110.647 169.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.31 -36.32 0.96 Allowed Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.42 -0.8 . . . . 0.0 113.663 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -57.56 -40.38 78.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.4 1.1 . . . . 0.0 110.014 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -107.05 150.89 26.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -73.74 172.67 11.06 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.605 0.717 . . . . 0.0 110.474 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.02 -50.7 69.67 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 109.686 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 1' ' ' GLU . 17.6 t0 -63.38 -46.37 86.78 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 122.514 1.149 . . . . 0.0 108.779 -177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.96 -61.04 2.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.53 1.932 . . . . 0.0 110.985 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.2 mm -44.83 -57.4 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 125.247 1.419 . . . . 0.0 109.642 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.36 -36.86 69.29 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.38 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.4 -48.4 45.06 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.16 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.448 -0.442 . . . . 0.0 110.104 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.67 -56.62 19.5 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.457 173.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.11 -45.42 64.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.06 0.544 . . . . 0.0 111.817 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -59.44 -56.79 17.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.101 0.96 . . . . 0.0 111.093 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.9 t -49.89 -44.87 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -58.32 -52.82 63.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.606 0.362 . . . . 0.0 111.029 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.14 -52.51 65.01 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 122.219 1.009 . . . . 0.0 111.545 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' HG2' ' CZ3' ' A' ' 89' ' ' TRP . 9.0 tp-100 -53.74 -51.95 61.7 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.074 2.55 . . . . 0.0 109.541 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.7 -54.69 20.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.062 0.945 . . . . 0.0 111.55 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.27 -49.01 62.04 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.551 1.14 . . . . 0.0 110.877 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.77 -9.49 75.03 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 118.71 -1.05 . . . . 0.0 113.102 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 41.94 60.33 2.27 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.473 1.109 . . . . 0.0 109.948 -160.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.54 -10.62 58.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 118.482 -0.771 . . . . 0.0 110.397 169.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.415 ' CZ3' ' HG2' ' A' ' 83' ' ' GLN . 12.0 m95 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 116.925 -1.512 . . . . 0.0 109.802 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.428 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . 2.38 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.09 47.28 2.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.796 1.238 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -72.89 150.6 42.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.86 0.838 . . . . 0.0 111.157 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.1 mt -74.85 -36.74 62.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.597 1.559 . . . . 0.0 109.98 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -46.99 61.69 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.736 0.698 . . . . 0.0 109.818 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.7 tp -49.83 -57.68 6.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.826 1.25 . . . . 0.0 108.67 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.52 -46.58 29.65 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -60.44 -54.56 44.1 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.664 -0.904 . . . . 0.0 110.72 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.03 -46.39 44.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.259 0.624 . . . . 0.0 111.006 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.47 -55.51 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -47.36 -60.98 2.13 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.281 1.433 . . . . 0.0 111.441 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -45.95 -41.19 11.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.954 2.101 . . . . 0.0 111.358 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.07 -44.0 6.87 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -104.13 -36.36 7.72 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.725 0.81 . . . . 0.0 112.303 -160.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.63 -46.84 3.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.312 1.045 . . . . 0.0 109.005 -161.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.1 -32.76 7.24 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.063 1.345 . . . . 0.0 112.182 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -38.68 -46.0 1.18 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.066 1.346 . . . . 0.0 112.339 170.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -106.45 -29.25 9.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.795 0.838 . . . . 0.0 110.898 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -113.2 28.64 8.62 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -169.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.34 130.72 3.78 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.249 0.931 . . . . 0.0 111.104 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 27.46 62.66 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.77 0.7 . . . . 0.0 113.205 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.5 32.04 76.57 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.771 -0.841 . . . . 0.0 111.401 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -86.98 -155.76 28.25 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -151.07 124.14 8.74 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.959 1.304 . . . . 0.0 107.861 166.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.59 -13.26 46.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.205 0.602 . . . . 0.0 111.757 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.9 t -104.12 -54.77 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.856 0.753 . . . . 0.0 110.536 -172.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 mt -115.7 91.04 28.57 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -42.43 -45.56 8.0 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 125.261 3.974 . . . . 0.0 116.276 -164.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -81.14 -20.16 41.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.409 1.484 . . . . 0.0 112.458 -173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -82.88 55.11 2.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.063 0.847 . . . . 0.0 109.493 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -78.42 175.82 9.93 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 125.677 1.591 . . . . 0.0 111.647 -171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -91.19 22.58 3.72 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.387 -0.821 . . . . 0.0 111.511 172.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -78.19 163.43 25.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.636 0.731 . . . . 0.0 110.296 175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -59.13 -55.83 30.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.734 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.27 27.38 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.168 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.0 -43.59 19.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.708 0.686 . . . . 0.0 110.333 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.76 -44.53 99.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.815 0.846 . . . . 0.0 110.609 -177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -69.32 -15.64 63.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -105.53 -63.18 1.27 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.117 1.367 . . . . 0.0 113.168 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -80.83 -28.28 36.21 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 124.4 11.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.622 0.646 . . . . 0.0 111.488 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.12 72.8 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.978 1.311 . . . . 0.0 110.198 169.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.23 -68.19 0.23 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 124.495 1.045 . . . . 0.0 111.302 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.33 -166.39 31.63 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.951 -2.46 . . . . 0.0 106.951 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -73.05 -108.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 118.427 1.114 . . . . 0.0 109.691 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 p30 53.17 -164.85 0.08 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.1 mm -103.31 -43.03 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.4 mp0 -49.84 -61.38 2.17 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.587 1.955 . . . . 0.0 110.416 -172.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.02 -44.45 70.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.586 1.554 . . . . 0.0 111.224 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.5 mm -58.23 -57.48 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.7 t -52.79 -52.3 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -45.82 -47.24 15.81 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.014 0.926 . . . . 0.0 111.854 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -53.49 56.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -57.57 -48.63 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.882 0.873 . . . . 0.0 110.806 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.98 -66.71 0.34 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.035 0.534 . . . . 0.0 109.614 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -85.83 -32.04 21.96 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.47 0.708 . . . . 0.0 112.188 -158.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.06 127.95 0.07 OUTLIER Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.785 1.183 . . . . 0.0 112.206 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -95.65 154.94 16.96 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.173 1.389 . . . . 0.0 109.702 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 27.92 -99.12 0.01 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.633 1.587 . . . . 0.0 115.449 169.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.76 29.97 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.69 1.196 . . . . 0.0 112.62 -174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.43 ' HB2' ' C1D' ' A' ' 90' ' ' HEM . 9.6 ttt -121.01 123.43 27.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 125.483 1.513 . . . . 0.0 109.81 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.52 137.84 57.6 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.342 2.695 . . . . 0.0 112.611 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.29 153.66 42.02 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.997 0.919 . . . . 0.0 109.442 167.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -122.09 -0.13 9.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.05 0.54 . . . . 0.0 112.079 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -49.3 136.54 15.54 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.305 0.574 . . . . 0.0 109.547 168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.79 -2.07 0.44 Allowed Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.774 1.654 . . . . 0.0 115.632 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -95.98 -41.04 8.97 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.991 1.896 . . . . 0.0 109.909 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.36 156.81 17.6 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.824 0.85 . . . . 0.0 108.973 174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.7 169.38 15.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.63 0.772 . . . . 0.0 110.339 173.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.96 -51.99 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.299 1.04 . . . . 0.0 109.906 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.75 -41.98 82.54 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.162 0.982 . . . . 0.0 109.441 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -52.9 -62.29 1.75 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.058 1.743 . . . . 0.0 110.691 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mm -44.61 -56.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.247 1.419 . . . . 0.0 109.935 172.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.23 73.04 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.478 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.17 -45.92 37.66 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.85 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 122.332 -0.51 . . . . 0.0 110.195 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -55.35 34.11 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.206 0.457 . . . . 0.0 111.193 170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.27 -42.55 63.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.231 0.612 . . . . 0.0 112.603 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -64.92 -52.77 54.59 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.655 -0.653 . . . . 0.0 110.79 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.65 -46.34 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 122.94 0.496 . . . . 0.0 109.743 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -54.76 -57.18 12.55 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.257 0.623 . . . . 0.0 110.572 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.08 -51.4 57.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.272 0.629 . . . . 0.0 111.379 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -53.85 -59.37 4.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.575 0.75 . . . . 0.0 109.748 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.71 94.5 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.692 0.797 . . . . 0.0 111.272 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.2 -49.73 73.25 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.603 1.161 . . . . 0.0 111.23 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 -0.52 88.73 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 123.835 0.71 . . . . 0.0 112.381 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.37 51.69 1.17 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.453 2.301 . . . . 0.0 111.84 -166.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -103.42 35.72 2.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.769 0.828 . . . . 0.0 111.167 -171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.0 m95 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 117.278 -1.344 . . . . 0.0 109.998 166.066 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HEM . . . . . 0.43 ' C1D' ' HB2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_